<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test - Kyrgiou, M - 2017 | Cochrane Library</title> <meta content="Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test - Kyrgiou, M - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009836.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test - Kyrgiou, M - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009836.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009836.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test" name="citation_title"/> <meta content="Maria Kyrgiou&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="m.kyrgiou@imperial.ac.uk" name="citation_author_email"/> <meta content="Ilkka Kalliala&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Anita Mitra" name="citation_author"/> <meta content="Imperial College London" name="citation_author_institution"/> <meta content="Christina Fotopoulou" name="citation_author"/> <meta content="Sadaf Ghaem-Maghami" name="citation_author"/> <meta content="Pierre PL Martin-Hirsch" name="citation_author"/> <meta content="Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust" name="citation_author_institution"/> <meta content="Margaret Cruickshank" name="citation_author"/> <meta content="Aberdeen Royal Infirmary" name="citation_author_institution"/> <meta content="Marc Arbyn&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Sciensano" name="citation_author_institution"/> <meta content="Evangelos Paraskevaidis&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Ioannina University Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD009836.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/01/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009836.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009836.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009836.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Colposcopy [*statistics &amp; numerical data]; Papillomaviridae [isolation &amp; purification]; Patient Compliance [statistics &amp; numerical data]; Precancerous Conditions [*diagnosis, *pathology]; Randomized Controlled Trials as Topic; *Referral and Consultation; Time Factors; Uterine Cervical Dysplasia [*diagnosis, *pathology]; Vaginal Smears [*statistics &amp; numerical data]; Watchful Waiting" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009836.pub2&amp;doi=10.1002/14651858.CD009836.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ytRBD0EW";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009836\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009836\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","fa","ms","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009836.pub2",title:"Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test",firstPublishedDate:"Jan 26, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009836.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009836.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009836.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009836.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009836.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009836.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009836.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009836.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009836.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009836.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5096 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009836.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0069"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-sec-0063"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/appendices#CD009836-sec-0074"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/table_n/CD009836StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/table_n/CD009836StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author custom-tooltip" title="Joint first author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Maria Kyrgiou</a><sup>a</sup></li> <li class="author custom-tooltip" title="Joint first author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0005">Ilkka Kalliala</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0006">Anita Mitra</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0007">Christina Fotopoulou</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0008">Sadaf Ghaem-Maghami</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0009">Pierre PL Martin-Hirsch</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0010">Margaret Cruickshank</a></li> <li class="author custom-tooltip" title="Joint senior author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0011">Marc Arbyn</a><sup>a</sup></li> <li class="author custom-tooltip" title="Joint senior author"><a href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information#CD009836-cr-0012">Evangelos Paraskevaidis</a><sup>a</sup></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information/en#CD009836-sec-0082">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 January 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009836.pub2">https://doi.org/10.1002/14651858.CD009836.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009836-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009836-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009836-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009836-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009836-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009836-abs-0001" lang="en"> <section id="CD009836-sec-0001"> <h3 class="title" id="CD009836-sec-0001">Background</h3> <p>A significant number of women are diagnosed with minor cytological abnormalities on cervical screening. Many authorities recommend surveillance as spontaneous regression might occur. However, attendance for cytological follow‐up decreases with time and might put some women at risk of developing invasive disease. </p> </section> <section id="CD009836-sec-0002"> <h3 class="title" id="CD009836-sec-0002">Objectives</h3> <p>To assess the optimum management strategy for women with minor cervical cytological abnormalities (atypical squamous cells of undetermined significance ‐ ASCUS or low‐grade squamous intra‐epithelial lesions ‐ LSIL) at primary screening in the absence of HPV (human papillomavirus) DNA test. </p> </section> <section id="CD009836-sec-0003"> <h3 class="title" id="CD009836-sec-0003">Search methods</h3> <p>We searched the following electronic databases: Cochrane Central Register of Controlled Trials (CENTRAL Issue 4, 2016), MEDLINE (1946 to April week 2 2016) and Embase (1980 to 2016 week 16). </p> </section> <section id="CD009836-sec-0004"> <h3 class="title" id="CD009836-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) comparing immediate colposcopy to cytological surveillance in women with atypical squamous cells of undetermined significance (ASCUS/borderline) or low‐grade squamous intra‐epithelial lesions (LSIL/mild dyskaryosis). </p> </section> <section id="CD009836-sec-0005"> <h3 class="title" id="CD009836-sec-0005">Data collection and analysis</h3> <p>The primary outcome measure studied was the occurrence of cervical intra‐epithelial neoplasia (CIN). The secondary outcome measures studied included default rate, clinically significant anxiety and depression, and other self‐reported adverse effects. </p> <p>We classified studies according to period of surveillance, at 6, 12, 24 or 36 months, as well as at 18 months, excluding a possible exit‐examination. We calculated pooled risk ratios (RR) and 95% confidence intervals (CI) using a random‐effects model with inverse variance weighting. Inter‐study heterogeneity was assessed with I<sup>2</sup> statistics. </p> </section> <section id="CD009836-sec-0006"> <h3 class="title" id="CD009836-sec-0006">Main results</h3> <p>We identified five RCTs with 11,466 participants that fulfilled the inclusion criteria. There were 18 cases of invasive cervical cancer, seven in the immediate colposcopy and 11 in the cytological surveillance groups, respectively. Although immediate colposcopy detects CIN2+ and CIN3+ earlier than cytology, the differences were no longer observed at 24 months (CIN2+: 3 studies, 4331 women; 17.9% versus 18.3%, RR 1.14, CI 0.66 to 1.97; CIN3+: 3 studies, 4331 women; 10.3% versus 11.9%, RR 1.02, CI 0.53 to 1.97). The inter‐study heterogeneity was considerable (I<sup>2</sup> greater than 90%). Furthermore, the inclusion of the results of the exit examinations at 24 months, which could inflate the CIN detection rate of cytological surveillance, may have led to study design‐derived bias; we therefore considered the evidence to be of low quality. </p> <p>When we excluded the exit examination, the detection rate of high‐grade lesions at the 18‐month follow‐up was higher after immediate colposcopy (CIN2+: 2 studies, 4028 women; 14.3% versus 10.1%, RR 1.50, CI 1.12 to 2.01; CIN3+: 2 studies, 4028 women, 7.8% versus 6.9%, RR 1.24, CI 0.77 to 1.98) both had substantial inter‐study heterogeneity (I<sup>2</sup> greater than 60%) and we considered the evidence to be of moderate quality). </p> <p>The meta‐analysis revealed that immediate referral to colposcopy significantly increased the detection of clinically insignificant cervical abnormalities, as opposed to repeat cytology after 24 months of surveillance (occurrence of koilocytosis: 2 studies, 656 women; 32% versus 21%, RR 1.49, 95% CI 1.17 to 1.90; moderate‐quality evidence) incidence of any CIN: 2 studies, 656 women; 64% versus 32%, RR 2.02, 95% CI 1.33 to 3.08, low‐quality evidence; incidence of CIN1: 2 studies, 656 women; 21% versus 8%, RR 2.58, 95% CI 1.69 to 3.94, moderate‐quality evidence). </p> <p>Due to differences in trial designs and settings, there was large variation in default rates between the included studies. The risk for default was higher for the repeat cytology group, with a four‐fold increase at 6 months, a six‐fold at 12 and a 19‐fold at 24 months (6 months: 3 studies, 5117 women; 6.3% versus 13.3%, RR 3.85, 95% CI 1.27 to 11.63, moderate‐quality evidence; 12 months: 3 studies, 5115 women; 6.3% versus 14.8%, RR 6.39, 95% CI 1.49 to 29.29, moderate‐quality evidence; 24 months: 3 studies, 4331 women; 0.9% versus 16.1%, RR 19.1, 95% CI 9.02 to 40.43, moderate‐quality evidence). </p> </section> <section id="CD009836-sec-0007"> <h3 class="title" id="CD009836-sec-0007">Authors' conclusions</h3> <p>Based on low‐ or moderate‐quality evidence using the GRADE approach and generally low risk of bias, the detection rate of CIN2+ or CIN3+ after two years does not appear to differ between immediate colposcopy and cytological surveillance in the absence of HPV testing, although women may default from follow‐up. Immediate colposcopy probably leads to earlier detection of high‐grade lesions, but also detects more clinically insignificant low‐grade lesions. Colposcopy may therefore be the first choice when good compliance is not assured. These results emphasize the need for an accurate reflex HPV triage test to distinguish women who need diagnostic follow‐up from those who can return safely to routine recall. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009836-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009836-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009836-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009836-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009836-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009836-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009836-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009836-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009836-abs-0002" lang="en"> <h3>Management of minor cytological abnormalities identified on cervical screening</h3> <p><b>The issue</b><br/>Cervical screening programmes reduce the risk of cervical cancer, through the use of cervical cytology (smear tests), which aim to detect and treat any precancerous changes which might put some women at risk of developing invasive disease (invasive cervical cancer) in the future. Usually only severe precancerous changes require treatment, however, there is some discrepancy in how to manage women with minor cytological changes (atypical squamous cells of undetermined significance (ASCUS/borderline) or low‐grade squamous intra‐epithelial lesions (LSIL/mild dyskaryosis) if HPV (human papillomavirus) testing is not routinely available. </p> <p><b>The aim of the review</b><br/>We aimed to assess whether immediate colposcopy or 'watchful waiting', with repeat cervical cytology, was better for women with minor cervical cytological abnormalities. </p> <p><b>What are the main findings?</b><br/>We included 5 randomised controlled trials including 11,466 participants with minor abnormalities on cervical cytology, treated either with immediate colposcopy or repetitive cytology. The included studies assessed differences in occurrence of cervical precancerous lesions between the two treatments. </p> <p>The results suggested that women attending immediate colposcopy after a single low‐grade abnormal cervical cytology test were more likely to have clinically insignificant findings detected than women who were managed with 'watchful waiting'. </p> <p>There were 18 cases of invasive cervical cancer, seven in the immediate colposcopy and 11 in the cytological surveillance groups. The detection rate of clinically insignificant low‐grade lesions was higher in the immediate colposcopy group, as was the detection rate of clinically more significant high‐grade precancerous lesions (CIN2 or CIN2 or worse) at 18 months, but not by 24 months. </p> <p>The risk of non‐compliance was significantly greater for the repeat cytology arm and increased with the length of the follow‐up. </p> <p><b>What is the quality of the evidence?</b> <br/>We graded the evidence as low to moderate quality. </p> <p><b>What are the conclusions?</b><br/>HPV DNA testing has been shown to be an effective triage tool for women with minor cervical cytology abnormalities. However, this test is not currently routinely available globally. Therefore, if HPV DNA testing is not available, immediate colposcopy is likely to detect more precancerous lesions earlier than cytological surveillance, but after two years there does not seem to be a difference between the two approaches. Women could be referred for immediate colposcopy after a single low‐grade abnormal or borderline cervical cytology test, if compliance with cytological surveillance is expected to be poor. When follow‐up compliance is expected to be good, repeat cervical cytology may be offered, as this may reduce the risk of over‐diagnosis and over‐treatment. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009836-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009836-sec-0069"></div> <h3 class="title" id="CD009836-sec-0070">Implications for practice</h3> <section id="CD009836-sec-0070"> <p>In the absence of HPV testing, women could be referred for immediate colposcopy after a single low‐grade or borderline cervical smear, if compliance with cytological surveillance is expected to be poor. When follow‐up compliance is expected to be good, repeated cytology may be preferred. This latter approach may reduce the risk of over‐diagnosis and over‐treatment (diagnosis and treatment of clinically insignificant lesions). Clinicians should be cautious and intervene only in women that are found to have high‐grade disease at colposcopy, in order to minimise the risk of over‐treatment. There is a clear need for a reflex triage method that can make distinction between women needing diagnostic work‐up and those who can be released safely to routine screening. </p> </section> <h3 class="title" id="CD009836-sec-0071">Implications for research</h3> <section id="CD009836-sec-0071"> <p>Immediate colposcopy may not increase the detection of high‐grade disease, compared to continued cytological surveillance over two years. Compliance, however, declines over time and is probably increased for women under cytological surveillance. In the absence of HPV test, a general policy could be immediate colposcopy after a single low‐grade or borderline cervical smear when poor compliance is anticipated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009836-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009836-sec-0008"></div> <div class="table" id="CD009836-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: occurrence of CIN and default rates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Immediate colposcopy compared with cytological surveillance for minor cervical cytological abnormalities: occurrence of different grades CIN in histology according to follow‐up time and default rates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with ASCUS or LSIL </p> <p><b>Settings:</b> colposcopy clinic </p> <p><b>Intervention:</b> immediate colposcopy </p> <p><b>Comparison:</b> cytological surveillance </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with cytological surveillance</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with immediate colposcopy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN2+ in histology at 18 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>101 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>151 per 1000</b><br/>(113 to 203) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.50</b> (1.12 to 2.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4028<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN2+ in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>209 per 1000</b><br/>(121 to 361) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.14</b> (0.66 to 1.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4331<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN3+ in histology at 18 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>69 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>86 per 1000</b><br/>(53 to 137) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.24</b> (0.77 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4028<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/><b>moderate<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN3+ in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b><br/>(63 to 234) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.02</b> (0.53 to 1.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4331<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>3,5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of any CIN in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>316 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>639 per 1000</b><br/>(420 to 974) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 2.02</b> (1.33 to 3.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>656<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>3,8</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Default rates at 6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b><br/>(80 to 728) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.85</b><br/>(1.27 to 11.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5117<br/>(3 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>moderate<sup>6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Default rates at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>413 per 1000</b><br/>(93 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 6.60</b><br/>(1.49 to 29.29 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5115<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>moderate<sup>7</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). For default rates the relative effect is calculated between cytological surveillance versus immediate colposcopy. For histology the relative effect is calculated between immediate colposcopy versus cytological surveillance.<br/><b>ASCUS</b> : atypical squamous cells of undetermined significance <b>CI:</b> Confidence interval; <b>CIN</b> : cervical intraepithelial neoplasia; <b>LSIL</b> : low‐grade squamous intra‐epithelial lesions; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded to moderate due to substantial inter‐study heterogeneity (P = 0.08, I<sup>2</sup>= 61%).<br/><sup>2</sup> Downgraded to low due to considerable inter‐study heterogeneity (P &lt; 0.00001, I<sup>2</sup>= 94%).<br/><sup>3</sup> Downgraded due to presence of the other possible bias resulting in falsely high CIN detection rate in the cytological surveillance arm.<br/><sup>4</sup> Downgraded to moderate due to substantial inter‐study heterogeneity (P = 0.02, I<sup>2</sup>= 75%).<br/><sup>5</sup> Downgraded to low due to considerable inter‐study heterogeneity (P &lt; 0.00001, I<sup>2</sup>= 93%).<br/><sup>6</sup> Downgraded to moderate due to considerable inter‐study heterogeneity (P = 0.02, I<sup>2</sup>= 76%).<br/><sup>7</sup> Downgraded to moderate due to considerable inter‐study heterogeneity (P = 0.0004, I<sup>2</sup>= 87%).<br/><sup>8</sup> Downgraded to low due to substantial inter‐study heterogeneity (P = 0.02, I<sup>2</sup> = 82%). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009836-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009836-sec-0009"></div> <p>Cervical cancer is largely preventable through screening and treatment of screen‐detected cervical lesions. Despite this, cervical cancer remains the most common female malignancy in virtually all low‐ and middle‐income countries, and the third most common in women worldwide (<a href="./references#CD009836-bbs2-0033" title="FerlayJ , SoerjomataramI , ErvikM , DikshitR , EserS , Mathers C et al, International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. globocan.iarc.fr accessed on 04/01/2017.">GLOBOCAN 2013</a>). Of all cervical cancer, 83% occurs in low‐income countries. Cervical cancer still remains an important public health issue in Europe with more than 66,000 new cases and 29,000 deaths annually. The majority of these cases are diagnosed in Eastern European countries, which reflects the absence of a screening programme (<a href="./references#CD009836-bbs2-0010" title="ArbynM , Primic-ZakeljM , RaifuAO , GrceM , ParaskevaidisE , DiakomanolisE , et al. The burden of cervical cancer in south-east Europe at the beginning of the 21st century. Collegium Antropologicum2007;31(Suppl 2):7-10.">Arbyn 2007</a>). A woman's risk of developing cervical cancer by age 75 years ranges from 0.9% in high‐income countries to 1.9% in low‐ and middle‐income countries (<a href="./references#CD009836-bbs2-0013" title="ArbynM , CastellsagueX , De SanjoseS , BruniL , SaraiyaM , BrayF , et al. Worldwide burden of cervical cancer in 2008. Annals of Oncology2011;22(12):2675-86.">Arbyn 2011</a>). In Europe, about 60% of women with cervical cancer are alive five years after diagnosis (<a href="./references#CD009836-bbs2-0029" title="MicheliA , CoeberghJW , MugnoE , MassimilianiE , SantM , OberaignerW , et al, EUROCARE. European health systems and cancer care. Annals of Oncology2003;14(Suppl 5):v41-60.">EUROCARE 2003</a>). The disease primarily affects younger women and therefore, the total years‐of‐life lost is proportionately higher than that for most other cancers, which often have a later onset.<br/><br/>The purpose of cervical cytology screening programmes using cytology (also known as Pap smear, named after Dr Papanicolaou (<a href="./references#CD009836-bbs2-0055" title="PapanicolaouGN , TrautHF . The diagnostic value of vaginal smears in carcinoma of the uterus. American Journal of Obstetrics and Gynecology1941;42:193-205.">Papanicolaou 1941</a>), is the early detection and treatment of pre‐invasive lesions and, ultimately, reduction in both the incidence and mortality from cervical cancer. Screening programmes have proven their value and efficacy in reducing both the incidence and mortality from cervical cancer in countries where they have been widely applied, including the UK. In countries with an established screening programme, there are different challenges: improving coverage and accuracy of screening, as well as the selection and better management of women with lesions of true malignant potential that require intervention. Without doubt, the most significant advance globally has been the realisation that persistent infection with oncogenic human papillomavirus (HPV) is causally associated with cervical cancer, as well as the development of prophylactic vaccines. The HPV DNA test that aims to detect the viral genome has also been developed and has potential clinical applications in primary screening, in the triage of minor cytological abnormalities, and in follow‐up after treatment (<a href="./references#CD009836-bbs2-0008" title="ArbynM , BuntinxF , Van RanstM , ParaskevaidisE , Martin-HirschJ, DillnerJ . Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. Journal of the National Cancer Institute2004;96(4):280-93.">Arbyn 2004</a>; <a href="./references#CD009836-bbs2-0021" title="BulkmansNW , BerkhofJ , RozendaalL , Van KemenadeFJ , BoekeAJ , BulkS , et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet2007;370(9601):1764-72.">Bulkmans 2007</a>; <a href="./references#CD009836-bbs2-0040" title="KoliopoulosG , ArbynM , Martin-HirschP , KyrgiouM , PrendivilleW , ParaskevaidisE . Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecologic Oncology2007;104(1):232-46.">Koliopoulos 2007</a>; <a href="./references#CD009836-bbs2-0053" title="NauclerP , RydW , TörnbergS , StrandA , WadellG , ElfgrenK , et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. New England Journal of Medicine2007;357(16):1589-97.">Naucler 2007</a>; <a href="./references#CD009836-bbs2-0057" title="ParaskevaidisE , ArbynM , SotiriadisA , DiakomanolisE , Martin-HirschP , KoliopoulosG , et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature. Cancer Treatment Reviews2004;30(2):205-11.">Paraskevaidis 2004</a>). </p> <section id="CD009836-sec-0010"> <h3 class="title" id="CD009836-sec-0010">Description of the condition</h3> <p>Cervical cytology may be classified according to the Bethesda system (<a href="./references#CD009836-bbs2-0061" title="SolomonD , DaveyD , KurmanR , MoriartyA , O'ConnorD , PreyM , et al: Forum Group Members. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA2002;287(16):2114-9.">Solomon 2002</a>), or the British Society of Cervical Cytology (BSCC) terminology (<a href="./references#CD009836-bbs2-0054" title="National Health Service Cervical Screening Programme. Achievable Standards, Benchmarks for Reporting, and Criteria for Evaluating Cervical Cytopathology. In: NHSCSP publication. 2nd edition. Vol. 1. Sheffield: NHS Cancer Screening Programmes, 2000:1-36.">NHSCSP 2000</a>), and can be reported in order of severity as: (1) normal; (2) atypical squamous cells of undetermined significance (ASCUS) (Bethesda)/borderline (BSCC); (3) low‐grade squamous intra‐epithelial lesion (LSIL) (Bethesda)/mild dyskaryosis (BSCC); (4) high‐grade squamous intraepithelial lesion (HSIL) (Bethesda)/high‐grade dyskaryosis (either favours moderate or severe) (BSCC). Cervical cytology classified as high‐grade (moderate and severe dyskaryosis in the UK) occurs in roughly 1% to 3% of the screened population. A high‐grade lesion (cervical intra‐epithelial neoplasia 2+ (CIN2+)) is confirmed by histology in greater than 50% to 60% of these cases. The risk of subsequent progression to malignancy is approximately 30%, although a significant proportion (20% to 30%) have regressive CIN. </p> <p>Although it is widely accepted that women with high grade cytological abnormalities should be referred immediately for a colposcopic examination or subsequent treatment, or both, uncertainty exists regarding the optimum way of managing those with low‐grade findings. </p> <p>Women with cytology classified as ASCUS or LSIL (Bethesda classification) (<a href="./references#CD009836-bbs2-0061" title="SolomonD , DaveyD , KurmanR , MoriartyA , O'ConnorD , PreyM , et al: Forum Group Members. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA2002;287(16):2114-9.">Solomon 2002</a>), or their British Society of Cervical Cytology (BSCC) terminology (<a href="./references#CD009836-bbs2-0054" title="National Health Service Cervical Screening Programme. Achievable Standards, Benchmarks for Reporting, and Criteria for Evaluating Cervical Cytopathology. In: NHSCSP publication. 2nd edition. Vol. 1. Sheffield: NHS Cancer Screening Programmes, 2000:1-36.">NHSCSP 2000</a>) equivalents of borderline and mild dyskaryosis, comprise approximately 7% of all the smears performed in the UK every year (<a href="./references#CD009836-bbs2-0027" title="Department of Health. Cervical Screening Programme, England: 2005–6. www.cancerscreening.nhs.uk/cervical/cervical-statistics-bulletin-2005-06.pdf (accessed 20 March 2012).">Department of Health 2006</a>). These minor abnormalities, with unknown or low malignant potential, are more common in younger women and present a difficult problem with regards to their management; the implications are important as they consume a disproportionate amount of clinical resources, with their significance still debatable. However, despite a low‐grade cytological smear, a considerable proportion of these women (15% to 20%) still have an underlying histological high‐grade lesion (CIN2+) (<a href="./references#CD009836-bbs2-0018" title="BolgerBS , LewisBV . A prospective study of colposcopy in women with mild dyskaryosis or koilocytosis. British Journal of Obstetrics and Gynaecology1988;95(11):1117-9.">Bolger 1988</a>; <a href="./references#CD009836-bbs2-0023" title="Contreras-MelendezL , HerbertA , Millward-SadlerGH , MooreIE , MassonGM , CamillieriAP , et al. Assessment of the accuracy of cytology in women referred for colposcopy and biopsy: the results of a 1 year audit. Cytopathology1992;3(5):267-74.">Contreras‐Melendez 1992</a>; <a href="./references#CD009836-bbs2-0030" title="FlannellyG , CampbellMK , MeldrumP , TorgersonDJ , TempletonA , KitchenerHC . Immediate colposcopy or cytological surveillance for women with mild dyskaryosis: a cost effectiveness analysis. Journal of Public Health Medicine1997;19(4):419-23.">Flannelly 1997</a>; <a href="./references#CD009836-bbs2-0032" title="GilesJA , DeeryA , CrowJ , WalkerP . The accuracy of repeat cytology in women with mildly dyskaryotic smears. British Journal of Obstetrics and Gynaecology1989;96(9):1067-70.">Giles 1989</a>; <a href="./references#CD009836-bbs2-0056" title="ParaskevaidisE , KaponisA , Malamou-MitsiV , DavidsonEJ , HirschPM , KoliopoulosG , et al. The natural history of HPV infection of the uterine cervix. Long-term observational and histological data. Anticancer Research2002;22(2B):1177-81.">Paraskevaidis 2002</a>; <a href="./references#CD009836-bbs2-0062" title="SoutterWP , WisdomS , BroughAK , MonaghanJM . Should patients with mild atypia in a cervical smear be referred for colposcopy?British Journal of Obstetrics and Gynaecology1986;93(1):70–4.">Soutter 1986</a>; <a href="./references#CD009836-bbs2-0067" title="WalkerEM , DodgsonJ , DuncanID . Does mild atypia on a cervical smear warrant further investigation?Lancet1986;2(8508):672-3.">Walker 1986</a>) and therefore, are at risk of developing invasive disease. </p> <p>The HPV test appears to have a role in the triage of those women who need referral to colposcopy. Evidence in the literature reports a significantly better sensitivity and similar specificity for the HPV test in comparison to repeat cytology for the detection of high‐grade lesions for initial ASCUS/borderline cytology (55% positivity). The introduction of the HPV DNA test in cases with ASCUS cytologic findings could enhance the detection of those women with underlying high‐grade CIN who should be referred to colposcopy or returned to routine recall instead of repeat cytology (<a href="./references#CD009836-bbs2-0008" title="ArbynM , BuntinxF , Van RanstM , ParaskevaidisE , Martin-HirschJ, DillnerJ . Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. Journal of the National Cancer Institute2004;96(4):280-93.">Arbyn 2004</a>; <a href="./references#CD009836-bbs2-0014" title="ArbynM , RoncoG , AnttilaA , MeijerCJ , PoljakM , OgilvieG , et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine2012;30 Suppl 5:F88-99.">Arbyn 2012</a>; <a href="./references#CD009836-bbs2-0039" title="KellyRS , PatnickJ , KitchenerHC , MossSM , NHSCSP HPV Special Interest Group. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. British Journal of Cancer2011;105(7):983-8.">Kelly 2011</a>). A survey amongst 43 European countries in 2013 showed that the majority (90%) of the countries have introduced HPV testing for ASCUS triage, and 62% use the test in the triage of LSIL as well (<a href="./references#CD009836-bbs2-0017" title="ArbynM , SnijdersPJ , MeijerCJ , BerkhofJ , CuschieriK , KocjanBJ , et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?Clinical Microbiology and Infection2015;21:817-26.">Arbyn 2015</a>). </p> <p>However, this does not appear to be true for LSIL/mild dyskaryosis lesions or women under 30 to 40 years, as the high‐positivity rate of HPV in this group (85%), does not support its use as a triage tool (<a href="./references#CD009836-bbs2-0009" title="ArbynM , ParaskevaidisE , Martin-HirschP , PrendivilleW , DillnerJ . Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high grade CIN: an update of pooled evidence. Gynecologic Oncology2005;99(3 Suppl 1):S7-S11.">Arbyn 2005</a>; <a href="./references#CD009836-bbs2-0015" title="ArbynM , RoelensJ , SimoensC , BuntinxF , ParaskevaidisE , Martin-HirschPPL , et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD008054.pub2]">Arbyn 2013a</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). Furthermore the HPV test is not yet widely available, reinforcing the need for clear recommendations in settings without access to these triage tests (<a href="./references#CD009836-bbs2-0024" title="CuzickJ , ArbynM , SankaranarayananR , TsuV , RoncoG , Mayrand MH , et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine2008;26(Suppl 10):K29–41.">Cuzick 2008</a>). </p> </section> <section id="CD009836-sec-0011"> <h3 class="title" id="CD009836-sec-0011">Description of the intervention</h3> <p>Until new, markedly reliable triage markers develop, the management options of LSIL cytology remain either immediate referral to colposcopy (examination of the cervix and vagina using magnifying light microscope, colposcope, and acetic acid) or cytological surveillance with repeat smears. </p> <p>A repeat cytology sample at six months may identify women with persistent lesions who require referral to colposcopy. </p> <p>The management after immediate referral to colposcopy will depend on the colposcopic findings. If they are suggestive of a high‐grade lesion, multiple punch biopsies may be appropriate, particularly in young women of reproductive age. If the colposcopic findings are consistent with a low‐grade lesion, surveillance every six months and treatment, only if the abnormality persists beyond two years, may be justified, particularly in young women, as a significant proportion of these lesions may regress. The rate of regression decreases significantly with increasing age, and in the presence of a high‐risk HPV subtype and increasing duration of presence of the lesion (<a href="./references#CD009836-bbs2-0043" title="KyrgiouM , ValasoulisG , FountaC , KoliopoulosG , KarakitsosP , NasioutzikiM , et al. Clinical management of HPV-related disease of the lower genital tract. Annals of the New York Academy of Sciences2010;1205:57-68.">Kyrgiou 2010</a>). </p> </section> <section id="CD009836-sec-0012"> <h3 class="title" id="CD009836-sec-0012">How the intervention might work</h3> <p>Optimising management of women with LSIL cervical cytology is difficult.</p> <p>A policy of immediate referral to colposcopy could potentially result, not only in increased numbers of referrals, thus overloading colposcopy clinics and increasing costs, but also in over‐intervention or over‐treatment, or both, due to subtle colposcopic findings. Many young women of reproductive age might be exposed to the physical and psychological sequelae of unnecessary interventions and treatment, which can also be associated with long‐term, pregnancy‐related, morbidity (<a href="./references#CD009836-bbs2-0011" title="ArbynM , KyrgiouM , SimoensC , RaifuAO , KoliopoulosG , Martin-HirschP , et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ2008;337:a1284.">Arbyn 2008</a>; <a href="./references#CD009836-bbs2-0031" title="FountaC , ArbynM , ValasoulisG , KyrgiouM , TsiliA , Martin-HirschP , et al. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG: An International Journal of Obstetrics and Gynaecology2010;117:1468-74.">Founta 2010</a>; <a href="./references#CD009836-bbs2-0041" title="KyrgiouM , KoliopoulosG , Martin-HirschP , ArbynM , PrendivilleE , ParaskevaidisE . Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet2006;367(9509):489-98.">Kyrgiou 2006</a>; <a href="./references#CD009836-bbs2-0044" title="KyrgiouM , ArbynM , Martin-HirschP , ParaskevaidisE . Increased risk of preterm birth after treatment for CIN. BMJ2012;345:e5847.">Kyrgiou 2012a</a>; <a href="./references#CD009836-bbs2-0045" title="KyrgiouM , MitraA , ArbynM , StasinouSM , Martin-HirschP , BennettP , et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ2014;349:g6192.">Kyrgiou 2014</a>; <a href="./references#CD009836-bbs2-0047" title="KyrgiouM , AthanasiouA , ParaskevaidiM , MitraA , KallialaI , Martin-HirschP , et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ2016;354:i3633.">Kyrgiou 2016a</a>; <a href="./references#CD009836-bbs2-0058" title="ParaskevaidisE , KyrgiouM , Martin-HirschP . Have we dismissed ablative treatment too soon in colposcopy practice?BJOG: An International Journal of Obstetrics and Gynaecology2007;114(1):3-4.">Paraskevaidis 2007</a>). </p> <p>On the other hand, triage with repeat cytology, and referral to colposcopy, only if the abnormality persists, may result in a potential reduction of the number of unnecessary referrals, but carries risks of missing high‐grade lesions and increased non‐attendance rates (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). Default from screening is known to put women with equivocal smears and occult high‐grade disease at risk of developing invasive cancer. </p> <p>The TOMBOLA study in the UK showed that, compared with cytological surveillance, a policy of immediate colposcopy does detect more high‐grade lesions, but might lead to over‐treatment. To reduce this, the trial authors suggested that a policy of targeted punch biopsies with subsequent treatment for CIN2 and CIN3, and cytological surveillance for CIN1 or less, provides the best balance between benefit and harm for the management of these women. Immediate loop excision resulted in over‐treatment and more adverse effects, and was therefore not be recommended (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). </p> </section> <section id="CD009836-sec-0013"> <h3 class="title" id="CD009836-sec-0013">Why it is important to do this review</h3> <p>This review aimed to appraise the current evidence from RCTs on cytological surveillance versus immediate colposcopy in the absence of HPV‐testing in order to make a decision on optimum evidence based practice, as currently this is an area of uncertainty. </p> <p>A list of abbreviations used in the text can be found in <a href="./appendices#CD009836-sec-0075">Appendix 1</a>. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009836-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009836-sec-0014"></div> <p>To assess the optimum management strategy for women with minor cervical cytological abnormalities (atypical squamous cells of undetermined significance ‐ ASCUS or low‐grade squamous intra‐epithelial lesions ‐ LSIL) at primary screening in the absence of HPV (human papillomavirus) DNA test. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009836-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009836-sec-0015"></div> <section id="CD009836-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009836-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included all RCTs comparing immediate referral to colposcopy versus cytological surveillance in women with ASCUS or LSIL cytological abnormalities at primary cervical screening in the absence of HPV DNA testing. We only included studies reporting combined data for minor abnormalities with more severe grades (high‐grade SIL, moderate and severe dyskaryosis), if separate data according to the grade were available. In case of overlap or duplicate reports, we extracted all relevant outcomes from all the publications of each trial. We included trials with multiple arms if at least two arms addressed an eligible comparison; non‐eligible arms were excluded. We excluded non‐randomised studies and pseudo‐randomised trials with alternate allocation of subjects; meeting and conference abstracts; and studies comparing HPV DNA test to colposcopy or repeat cytology. </p> </section> <section id="CD009836-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included studies with adult women (greater than 18 years old) with minor cytological cervical abnormalities (ASCUS/borderline dyskaryosis and LSIL/mild dyskaryosis). From included studies we excluded women with high‐grade squamous intra‐epithelial lesions (HSIL)/moderate and severe dyskaryosis, when separate data for LSIL abnormalities were available. </p> </section> <section id="CD009836-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Surveillance with repeat cytology in any setting versus immediate colposcopy.</p> <p>The gold standard was histological diagnosis at colposcopy or at the end of the surveillance period in the form of punch biopsies or excisional treatment. Excisional treatment included large loop excision of the transformation zone (LLETZ or LEEP), laser conization (LC), cold knife conization (CKC) and needle or straight wire excision of the transformation zone (NETZ/SWETZ). We excluded trials that did not report on histological results (gold standard) (for example, in the form of punch biopsies or excisional treatment). </p> </section> <section id="CD009836-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD009836-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>The primary outcomes were the cumulative incidence of cervical intra‐epithelial neoplasia grade 2 or worse (CIN2+) and grade 3 or worse (CIN3+) from histology assessment. </p> </section> <section id="CD009836-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>The secondary outcomes included:</p> <p> <ul id="CD009836-list-0001"> <li> <p>cumulative incidence at other histological thresholds, including HPV‐associated morphological findings and CIN1; </p> </li> <li> <p>default rates from repeat cytology or colposcopy clinic appointments;</p> </li> <li> <p>anxiety and depression scores (based on validated questionnaires);</p> </li> <li> <p>short‐term adverse effects of management (pain, bleeding, and discharge, together with the duration (in days) and severity; and </p> </li> <li> <p>treatment rates in both groups.</p> </li> </ul> </p> </section> </section> </section> <section id="CD009836-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for papers in all languages.</p> <p>We searched the literature from 1946, when the conservative methods of treatment for CIN were first introduced into clinical practice, and included references published up to the present day. </p> <p>We identified the RCTs comparing these alternative strategies for the management of low‐grade cervical abnormalities by a computerised literature search, by tracing references listed in relevant articles and by a manual search of appropriate journals. </p> <section id="CD009836-sec-0024"> <h4 class="title">Electronic searches</h4> <p>See: <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/gynaeca/frame.html" target="_blank">Cochrane Gynaecological Cancer Group</a> methods used in reviews.<br/>We searched the following electronic databases. </p> <p> <ul id="CD009836-list-0002"> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL, 2016, Issue 4)</p> </li> <li> <p>MEDLINE (Ovid) (1946 to April week 2, 2016)</p> </li> <li> <p>Embase (Ovid) (1980 to 2016, week 16)</p> </li> </ul> </p> <p>We used the following main keywords: ‘randomised controlled trials’ ‘cervical intraepithelial neoplasia (CIN)’, ‘cervical cancer’, ‘ASCUS’, ‘borderline’, ‘LSIL’, ‘low‐grade squamous intra‐epithelial lesion’, ‘mild dyskaryosis’, ‘colposcopy’, ‘smear’, ‘cytology’. </p> <p>We used the 'related articles' feature in MEDLINE to retrieve additional references. For databases other than MEDLINE, we adapted the search strategy accordingly. The search strategies for all the databases are available in <a href="./appendices#CD009836-sec-0076">Appendix 2</a>, <a href="./appendices#CD009836-sec-0077">Appendix 3</a> and <a href="./appendices#CD009836-sec-0078">Appendix 4</a>. </p> </section> <section id="CD009836-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We searched the metaRegister of controlled trials (<a href="http://www.isrctn.com/page/mrct" target="_blank">www.isrctn.com/page/mrct</a>), the National Cancer Institute's database (<a href="http://www.cancer.gov/clinicaltrials" target="_blank">www.cancer.gov/clinicaltrials</a>), Physicians Data Query (<a href="http://www.cancer.gov/publications/pdq" target="_blank">www.cancer.gov/publications/pdq</a>), Current Controlled Trials (<a href="http://www.controlled-trials.com" target="_blank">www.controlled-trials.com</a>), and ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) for ongoing studies. </p> <p>We searched conference proceedings and abstracts through Zetoc (<a href="http://zetoc.mimas.ac.uk" target="_blank">http://zetoc.mimas.ac.uk</a>) and WorldCat Dissertations (<a href="http://www.oclc.org/support/documentation/firstsearch/databases/dbdetails/details/WorldCatDissertations.htm" target="_blank">www.oclc.org/support/documentation/firstsearch/databases/dbdetails/details/WorldCatDissertations.htm</a>). We also searched reports of conferences in the following sources. </p> <p> <ul id="CD009836-list-0003"> <li> <p>Annual Meetings of the British Society of Colposcopy and Cervical Pathology.</p> </li> <li> <p>Triannual Meetings of the International Federation of Cervical Pathology and Colposcopy.</p> </li> <li> <p>Triannual Meetings of the European Federation of Colposcopy.</p> </li> <li> <p>Annual Meetings of the American Society of Colposcopy and Cervical Pathology.</p> </li> </ul> </p> <p>We checked the citation lists of included studies and contacted experts in the field, Presidents of the British, European, American and International Societies of Colposcopy and Cervical Pathology to identify further reports of studies. </p> <p>We intended to include both published and unpublished studies, if they met the inclusion criteria for the review. </p> </section> </section> <section id="CD009836-sec-0026"> <h3 class="title" id="CD009836-sec-0026">Data collection and analysis</h3> <section id="CD009836-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We downloaded all titles and abstracts retrieved by electronic searching into the reference management database <a href="http://endnote.com/" target="_blank">Endnote</a>. We removed duplicates and two review authors (MK, IK) independently examined the remaining references. We excluded those trials which clearly did not meet the inclusion criteria, and obtained copies of the full text of potentially relevant references. We (MK, IK) independently assessed the eligibility of the retrieved papers. We then compared the results and resolved any disagreements by discussion. If necessary, we involved a third review author (MA) to reach consensus. We documented the reasons for exclusion. </p> </section> <section id="CD009836-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We (MK, IK) extracted the relevant data from the trials identified. This included study population, population characteristics, sample size, study methods, method of randomisation, methodological quality, follow‐up and dropout, assessment of outcomes, and results). </p> <p>We classified trials according to the length of cytological surveillance (6, 12, 18, 24, 30, and 36 months) and analysed them in different groups. </p> <p>We extracted or computed from all included studies, the total number of women included and incidence of all grades of histological diagnoses, default rates, depression, anxiety scores, after‐effects and other patient‐reported outcomes in both groups, whenever available. We contacted trial authors to obtain separate data when data on LSILs were merged with HSIL lesions. </p> <p>In addition, we collected data on the length of period of surveillance and the type of histology used at the end of surveillance or at colposcopy (gold standard: punch biopsies or excisional treatment). </p> <p>We also documented the diagnostic criteria used for the interpretation of cytology and histology in each study, where these were read, and whether there was a central review in each study in order to assess if the above had significant variation that may have impacted on the value of the review. </p> <p>For included trials, we extracted the following data.</p> <p> <ul id="CD009836-list-0004"> <li> <p>Author, year of publication, journal and language</p> </li> <li> <p>Country</p> </li> <li> <p>Setting where the trial was conducted</p> </li> <li> <p>Inclusion and exclusion criteria</p> </li> <li> <p>Trial design, methodology</p> </li> <li> <p>Trial population</p> <ul id="CD009836-list-0005"> <li> <p>total number enrolled and number included in each group</p> </li> <li> <p>participant characteristics (such as age and other demographic and socioeconomic characteristics ‐ risk factors for cervical cancer) </p> </li> <li> <p>index cytology, history of previous cytological lesions</p> </li> <li> <p>type of cytology (conventional or liquid‐based)</p> </li> </ul> </li> <li> <p>Intervention details</p> <ul id="CD009836-list-0006"> <li> <p>surveillance with repeat cytology in primary care and number of follow‐up smears</p> </li> <li> <p>immediate colposcopy and related interventions (i.e. punch biopsies and/or treatment and type) </p> </li> <li> <p>the type of gold standard used (histology at colposcopy or at the end of the surveillance period): punch biopsies or excisional treatment. We planned to report the type of excisional treatment: LLETZ or LEEP, LC, CKC and NETZ or SWETZ. </p> </li> </ul> </li> <li> <p>Risk of bias (See <a href="#CD009836-sec-0029">Assessment of risk of bias in included studies</a>) </p> </li> <li> <p>Outcomes reported in each trial</p> <ul id="CD009836-list-0007"> <li> <p>Primary outcomes:</p> <ul class="plain" id="CD009836-list-0008"> <li> <ul id="CD009836-list-0009"> <li> <p>the cumulative incidence of CIN2+ and CIN3+ at histology</p> </li> </ul> </li> </ul> </li> <li> <p>Secondary outcomes:</p> <ul id="CD009836-list-0010"> <li> <p>cumulative incidence at other histological thresholds HPV‐associated morphological findings and CIN1 </p> </li> <li> <p>default rates from repeat cytology or colposcopy clinic appointments</p> </li> <li> <p>treatment rates in both groups</p> </li> <li> <p>anxiety scores</p> </li> <li> <p>depression scores</p> </li> <li> <p>short‐term after‐effects of management (rates and types), specifically pain, bleeding, and discharge, together with the duration (in number of days) and severity </p> </li> <li> <p>other self‐reported outcomes</p> </li> </ul> </li> </ul> </li> </ul> </p> <p> <ul class="plain" id="CD009836-list-0011"> <li> <ul id="CD009836-list-0012"> <li> <p>Details of outcomes reported:</p> <ul id="CD009836-list-0013"> <li> <p>for each outcome: outcome definition (with diagnostic criteria if relevant)</p> </li> <li> <p>unit of measurement (if relevant)</p> </li> <li> <p>for scales: upper and lower limits, and whether high or low score is good</p> </li> <li> <p>results: number of participants allocated to each intervention group</p> </li> <li> <p>for each outcome of interest: sample size; missing participants</p> </li> <li> <p>the time points at which outcomes were collected and reported</p> </li> </ul> </li> </ul> </li> </ul> </p> <p>We extracted data on outcomes as below.</p> <p> <ul id="CD009836-list-0014"> <li> <p>For dichotomous outcomes (all outcomes were reported as dichotomous), we extracted the number of women in each treatment arm who experienced the outcome of interest and the number of women assessed at endpoint, in order to estimate a risk ratio (RR). </p> </li> </ul> </p> <p>We (MK, IK) independently extracted data in a data extraction form specially designed for the review. We resolved differences between review authors by discussion or by appeal to a third review author (MA), if necessary. </p> </section> <section id="CD009836-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the Cochrane tool for assessing risk of bias (<a href="./references#CD009836-bbs2-0035" title="HigginsJPT , AltmanDG , Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We (MK, IK) independently assessed the risk of bias within each included study based on the following six domains, with our judgements presented as 'low risk of bias'; 'high risk of bias', and 'unclear'. </p> <p>For RCTs, if identified, we included assessment of:</p> <p> <ul id="CD009836-list-0015"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding (of participants, healthcare providers and outcome assessors);</p> </li> <li> <p>incomplete outcome data:</p> <ul id="CD009836-list-0016"> <li> <p>we recorded the proportion of participants whose outcomes were not reported at the end of the study; we noted if loss to follow‐up was not reported. We coded the satisfactory level of loss to follow‐up for each outcome as: </p> <ul id="CD009836-list-0017"> <li> <p>'low risk of bias', if fewer than 20% of participants were lost to follow‐up, and reasons for loss to follow‐up were similar in both treatment arms </p> </li> <li> <p>'high risk of bias', if more than 20% of participants were lost to follow‐up, or reasons for loss to follow‐up differed between treatment arms </p> </li> <li> <p>'unclear' if loss to follow‐up was not reported;</p> </li> </ul> </li> </ul> </li> <li> <p>selective reporting of outcomes; and</p> </li> <li> <p>other possible sources of bias.</p> </li> </ul> </p> </section> <section id="CD009836-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For all (dichotomous) outcomes, we used the risk ratio (RR).</p> </section> <section id="CD009836-sec-0031"> <h4 class="title">Dealing with missing data</h4> <p>We contacted one study author to obtain data stratified by grade of index cytology (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). Otherwise, all relevant data were available from the original publications. We did not impute any missing outcome data. </p> </section> <section id="CD009836-sec-0032"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed inter‐study heterogeneity with the Cochran Q test (<a href="./references#CD009836-bbs2-0022" title="CochranWG . The combination of estimates from different experiments. Biometrics1954;10:101-29.">Cochran 1954</a>), by visual inspection of forest plots (<a href="./references#CD009836-bbs2-0026" title="DeeksJJ , HigginsJPT , Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Deeks 2011</a>), by estimation of the percentage of heterogeneity between studies which cannot be ascribed to sampling variation (I<sup>2</sup> statistic) (<a href="./references#CD009836-bbs2-0034" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557–60.">Higgins 2003</a>), and by a formal test of the significance for heterogeneity (<a href="./references#CD009836-bbs2-0025" title="DeeksJJ , AltmanDG , BradburnMJ . Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM , Davey SmithG , AltmanDG , editors(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd edition. London: BMJ Publication Group, 2001.">Deeks 2001</a>). If there was evidence of substantial heterogeneity, we investigated and reported the possible reasons for it. </p> </section> <section id="CD009836-sec-0033"> <h4 class="title">Assessment of reporting biases</h4> <p>We explored potential publication bias graphically in the funnel plot (<a href="./references#CD009836-bbs2-0064" title="SterneJAC , EggerM , Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Sterne 2011</a>). </p> </section> <section id="CD009836-sec-0034"> <h4 class="title">Data synthesis</h4> <p>When sufficient clinically similar studies were available, we pooled their results in meta‐analyses. We calculated the risk ratio (RR) and 95% confidence intervals (95% CI) for each reported outcome in the immediate colposcopy versus repeat cytology arm for dichotomous outcomes using the Cochrane Review Manager 5 software (<a href="./references#CD009836-bbs2-0059" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We used random‐effects models with inverse variance weighting for all meta‐analyses (<a href="./references#CD009836-bbs2-0028" title="DersimonianR , LairdNM . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7:177–88.">Dersimonian 1986</a>). If data were not of suitable quality for meta‐analysis, we presented the data in tables and discussed the data in the text of the review. We analysed data according to different lengths of surveillance: 6, 12, 18, 24, 30, 36 or more months. </p> </section> <section id="CD009836-sec-0035"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed a subgroup analysis and analysed the data separately for ASCUS/borderline and LSIL/mild dyskaryosis smears, wherever possible. </p> </section> <section id="CD009836-sec-0036"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis excluding one trial (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) that showed opposite evidence compared to other included studies. No additional sensitivity or subgroup analyses were possible due to the small number of studies in each meta‐analysis. </p> </section> <section id="CD009836-sec-0037"> <h4 class="title">Quality of evidence</h4> <p>We presented the overall quality of the evidence for each outcome according to the GRADE approach, which takes into account issues not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity such as directness of results (<a href="./references#CD009836-bbs2-0049" title="LangendamMW , AklEA , DahmP , GlasziouP , GuyattG , SchunemannHJ . Assessing and presenting summaries of evidence in Cochrane Reviews. Systematic Reviews2013;23(2):81.">Langendam 2013</a>)<i>.</i> We created a 'Summary of findings' table based on the methods described the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD009836-bbs2-0060" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a>) and using <a href="http://gradepro.org/" target="_blank">GRADEpro GDT</a>. We used the GRADE checklist and GRADE Working Group quality of evidence definitions (<a href="./references#CD009836-bbs2-0050" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82.">Meader 2014</a>). </p> <p> <ul id="CD009836-list-0018"> <li> <p><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p><b>Very low quality:</b> We are very uncertain about the estimate. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009836-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009836-sec-0038"></div> <section id="CD009836-sec-0039"> <h3 class="title">Description of studies</h3> <p>The characteristics of the included and excluded studies and the outcomes examined are described in the <a href="./references#CD009836-sec-0088" title="">Characteristics of included studies</a> and <a href="./references#CD009836-sec-0089" title="">Characteristics of excluded studies</a> tables. </p> <section id="CD009836-sec-0040"> <h4 class="title">Results of the search</h4> <p>The searches identified 5176 records (4715 after de‐duplication). We screened the abstracts and excluded 4699 records. We identified 16 potentially eligible full‐text articles for further assessment. We did not identify any unpublished studies. Altogether eight of the 16 identified full‐text articles were supporting reports of the same large trial (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) and two full‐text articles reported the same outcomes for one trial (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>), but separately, depending on the initial histology of ASCUS or LSIL. We excluded a further two studies after full text review: one that was not a RCT (<a href="./references#CD009836-bbs2-0006" title="De BieRP , MassugerLFAG , DongenRAJM , SnijdersMPML , BultenJ , MelchersWJG , et al. To treat or not to treat; the clinical dilemma of atypical squamous cells of undetermined significance (ASC-US). Acta Obstetrics and Gynecology Scandinavica2011;90(4):313-8. ">De Bie 2011</a>), and one study that did not report required outcomes (<a href="./references#CD009836-bbs2-0007" title="ElitL , LevineMN , JulianJA , SellorsJW , LytwynA , ChongS , et al. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil. Cancer2011;117(7):1438-45. ">Elit 2011</a>). After combinations and exclusions, five unique studies fulfilled the inclusion criteria of this review (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). More details of the literature search and the reasons for exclusion are presented in the PRISMA flowchart (<a href="./references#CD009836-bbs2-0051" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open medicine: a peer-reviewed, independent, open-access journal2009;3:e123-30.">Moher 2009</a>) (<a href="#CD009836-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD009836-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD009836-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD009836-sec-0041"> <h4 class="title">Included studies</h4> <p>The detailed characteristics of the included studies are shown in <a href="./references#CD009836-sec-0088" title="">Characteristics of included studies</a> and individual outcomes in <a href="#CD009836-tbl-0002">Table 1</a>. The five studies included 11,466 participants. All studies were, one conducted in the USA (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) and four in the UK (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). Four studies explored the two management strategies in women with either ASCUS (borderline) or LSIL (mild dyskaryosis) (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), and one study looked at women with mild or moderate dyskaryosis (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). We obtained separate data for women referred with mild or moderate dyskaryosis from the study authors (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>) and only included women with mild dyskaryosis in the analysis. All studies assessed non‐attendance and the rates for different CIN grades at histology for the immediate colposcopy group, as compared to the histological diagnosis at the end of the surveillance period. Two studies (<a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) assessed the psychological morbidity of the different approaches (i.e. anxiety, depression and other self‐reported outcomes). The length of the surveillance period varied between studies. Three of the included RCTs followed up women for up to 24 months (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>), one for 12 months (<a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>) and another for 36 months (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). One study had four arms with different lengths of follow‐up (immediate colposcopy versus surveillance for 6, 12, or 24 months) (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). Three studies provided interim histological results (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), while two of the studies provided results only at the end of the surveillance period (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>). The largest trial randomised 5060 women (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) and the smallest 353 (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). </p> <div class="table" id="CD009836-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reported individual outcomes in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Immediate colposcopy</b> </p> <p><b>n/N (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytological surveillance</b> </p> <p><b>n/N (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR + 95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a><b>(ASCUS)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/1163 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/1164 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 [1.49, 3.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/1163 (10.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92/1164 (7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 [1.00, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/1163 (5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/1164 (5.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.62, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/1163 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/1164 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.02 [0.72,1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/1163 (10.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/1164 (14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 [0.57, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/1163 (5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108/1164 (9.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 [0.39, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15/1163 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165/1164 (14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.99 [6.52, 18.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a><b>(LSIL)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/673 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/675 (5.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.76 [1.18, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127/673 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95/675 (14.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.34 [1.05, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/673 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/675 (8.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09 [0.78, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/673 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/675 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09 [0.78,1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127/673 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/675 (22.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.68, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/673 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93/675 (13.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69 [0.51, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/673 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110/675 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.42 [10.17, 73.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28/160 (17.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.52 [0.28, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86/160 (53.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.55 [1.32, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/160 (16.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 [0.57, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/160 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36 [0.85, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/160 (36.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 [1.45, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33/160 (20.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.21 [1.55, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/158 (11.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.40, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96/158 (60.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.37 [1.19, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/158 (15.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 [0.60, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/158 (16.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.34 [0.84, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1 / 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55/145 (37.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/158 (32.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.18 [0.86, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/158 (44.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 [1.22, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/158 (28.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 [1.18, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11/158 (7.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 [0.60, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53/158 (33.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.49 [1.97, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/158 (5.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.78 [1.33, 5.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/158 (7.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.91 [1.56, 5.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44/158 (27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.43 [1.84, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/158 (20.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25 [1.57, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/160 (11.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.37 [2.15, 580.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/158 (14.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.16 [2.65, 704.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38/158 (24.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.70 [4.38, 1140.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83/130 (63.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/243 (29.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 [1.73, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1 / 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/130 (46.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47/243 (19.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.43 [1.77, 3.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22/130 (16.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/243 (9.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.71 [1.00, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/130 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46/243 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.92 [2.01, 12.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/130 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95/243 (39.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.16 [4.24, 24.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>GHQ caseness</b> <b><sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Choice</b> <b><sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No choice</b> <b><sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134/233 (58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/241 (49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16 [0.98, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 months (pre visit)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/183 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77/190 (41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 [0.75, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 months (post visit)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/175 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/177 (37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 [0.68, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40/135 (29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/127 (28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 [0.73, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/182(4.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/171 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.76 [0.81, 17.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43/182 (23.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/171 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.53 [1.48, 4.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/182 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14/171(8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 [1.31, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92/182 (50.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57/171 (33.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.52 [1.17, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88/182 (48.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/171 (29.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.62 [1.23, 2.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/182 (24.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/171 (9.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.49 [1.48, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/182 (4.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/171 (5.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 [0.30, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43/182 (23.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34/171 (19.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19 [0.80, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/182 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/171 (14.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.37 [0.85, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/182 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/171 (21.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.32 [5.31, 276.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tombola 2009</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 30 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/2216 (8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101/2223 (4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80 [1.42, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>369/2216 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>269/2223 (12.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.38 [1.19, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>188/2216 (8.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/2223 (7.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.12 [0.92, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 36 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/2216 (8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>157/2223 (7.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16 [0.94, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>369/2216 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>350/2223 (15.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 [0.93, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>188/2216 (8.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>193/2223 (8.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 [0.81, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/2216 (6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/2223 (12.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.88 [1.56, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/2216 (6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>327/2223 (14.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16 [1.80, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>304/782 (38.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>145/968 (15.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.60 [2.18, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/774 (18.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56/965 (5.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 [2.39, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bleeding</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any bleeding</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>366/781 (46.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>166/967 (17.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.73 [2.33, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/772 (18.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/961 (1.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.20 [6.74, 18.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Discharge</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any discharge</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267/780 (34.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83/964 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.98 [3.17, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133/777 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/962 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.57 [3.20, 6.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anxiety</b> <b><sup>e</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/751 (7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/900 (13.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58 [0.43, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190/1161 (16.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>218/1130 (19.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 [0.71, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162/1050 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/1008 (17.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.72, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/1001 (17.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/962 (18.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 [0.81, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>146/949 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>143/887 (16.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 [0.77, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Depression</b> <b><sup>f</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50/757 (6.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68/902 (7.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.62, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110/1162 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132/1136 (11.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 [0.64, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/1052 (10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114/1016 (11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 [0.70, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/1001 (11.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104/964 (10.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 [0.80, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101/948 (10.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108/887 (12.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.68, 1.13]</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>For Immediate colposcopy, n = n at immediate colposcopy visit, possible follow‐up excluded. </p> <p><sup> a</sup> Cumulative incidence during follow‐up, excluding the exit examination or deferred treatment. </p> <p><sup> b</sup> GHQ caseness = GHQ (General Health Questionnaire) score ≥ 4. </p> <p><sup> c</sup> Analysis for this outcome between the original randomization groups. </p> <p><sup> d</sup> Based on Questionnaire 6 weeks after immediate colposcopy or first cytological surveillance visit. </p> <p><sup> e</sup> ≥ 11 on hospital anxiety and depression anxiety subscale </p> <p><sup> f</sup> ≥ 8 on hospital anxiety and depression subscale </p> </div> </div> <p>The design, management protocol and exit examination somewhat varied for different studies. <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> randomly allocated women into four groups: immediate colposcopy, or 6, 12 and 24 months' surveillance. All recruited women underwent LLETZ at the conclusion of their study arm that was preceded by a directed punch biopsy, if a distinct lesion was seen. Women were withdrawn if there were severe cytological abnormalities or colposcopic impression of possible microinvasion. <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> had a similar design and treated all women immediately on the day of recruitment or at the completion of 24 months of surveillance. Women were treated during follow‐up, if the follow‐up smear showed severe dyskaryosis or worse. </p> <p><a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> had a different design and randomised women into two principal groups: cytological surveillance for 12 months (with colposcopy and treatment when necessary at 6 or 12 months, if either follow‐up smear was abnormal) versus the choice to have surveillance or immediate colposcopy and treatment when necessary. Results on attendance rates were presented for 6 and 12 months' surveillance. In <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> (the Trial Of Management of Borderline and Other Low grade Abnormal smears) women were followed up at 6‐month intervals for 36 months in the cytological surveillance arm. The follow‐up, as well as the immediate colposcopy, were done within a routine nationwide healthcare practice. Moderate dyskaryosis or worse, or three consecutive inadequate results led to referral to colposcopy, whereas women who reverted to normal were discharged to "routine 3‐yearly recall" after three consecutive normal smears. Women allocated to immediate colposcopy were further randomised to either immediate treatment (LLETZ) or directed biopsies with selective recall for treatment, if the colposcopy was adequate and showed abnormalities (no additional procedures were carried out if the colposcopy was normal). Women from both arms were recalled for exit examination at 36 months that included colposcopy and LLETZ if the transformation zone was abnormal. </p> <p>In the <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> (ASCUS‐LSIL Triage Study) trial, all women after randomisation had a repeat liquid‐based cytology sample (LBC) for cytology and HPV testing at enrolment. Women in the cytological surveillance arm were followed up for 24 months at 6‐month intervals with pelvic examination, cervical smear, HPV‐test and cervicography taken at each visit. If the cytology suggested HSIL or worse at enrolment or during surveillance, women were referred to colposcopy with treatment if CIN2 or worse was detected on a biopsy. The immediate‐colposcopy‐arm women underwent a colposcopic examination on the same day or within 3 weeks from recruitment and received treatment if CIN2 or 3 was detected at biopsy. Women from both arms were recalled for exit colposcopy at 24 months; treatment was performed if CIN2 or 3 was detected on biopsy and for women with CIN1 with history of LSIL or HPV+ ASCUS during at least one of the previous two visits. </p> </section> <section id="CD009836-sec-0042"> <h4 class="title">Excluded studies</h4> <p>Studies excluded during full‐text review are described in the <a href="./references#CD009836-sec-0089" title="">Characteristics of excluded studies</a> table. The reasons for exclusion were non‐randomised design in one (<a href="./references#CD009836-bbs2-0006" title="De BieRP , MassugerLFAG , DongenRAJM , SnijdersMPML , BultenJ , MelchersWJG , et al. To treat or not to treat; the clinical dilemma of atypical squamous cells of undetermined significance (ASC-US). Acta Obstetrics and Gynecology Scandinavica2011;90(4):313-8. ">De Bie 2011</a>) and in one study the exposure of interest was low‐grade histological changes (CIN1 to 2) instead of cytological changes (<a href="./references#CD009836-bbs2-0007" title="ElitL , LevineMN , JulianJA , SellorsJW , LytwynA , ChongS , et al. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia: a randomized trial in Canada and Brazil. Cancer2011;117(7):1438-45. ">Elit 2011</a>). </p> </section> </section> <section id="CD009836-sec-0043"> <h3 class="title">Risk of bias in included studies</h3> <p>Generally we considered the risk of selection and reporting biases across included trials to be low. The risk of performance bias and other possible sources of bias we considered high in all included trials. Risk of detection bias (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), as well as attrition bias (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) were each considered low in only one trial. We have presented the quality assessment of the included RCTs with the Cochrane tool in <a href="#CD009836-sec-0043">Risk of bias in included studies</a> and in <a href="#CD009836-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD009836-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009836-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <section id="CD009836-sec-0044"> <h4 class="title">Allocation</h4> <p>We considered the random sequence generation appropriate in all studies and the allocation concealment in all but one study (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>), which did not describe the allocation concealment process in full. </p> </section> <section id="CD009836-sec-0045"> <h4 class="title">Blinding</h4> <p>Blinding of participants and personnel was not possible given the nature of the intervention. There was no blinding of the outcome in two studies (<a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>), while the risk of detection bias was low in <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> and unclear in the remaining studies (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> and <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> stated that the outcome assessors were not blinded. <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> described no details of the blinding. <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> reported that all clinical information were unmasked during the exit examination, but included no description of the blinding of the assessors during the follow‐up period. <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> described that the colposcopists performing the exit examination were blinded to the initial cytology results, the randomisation arm and the clinical events that occurred after randomisation, although it is unclear whether the personnel were blinded during surveillance. </p> </section> <section id="CD009836-sec-0046"> <h4 class="title">Incomplete outcome data</h4> <p>Loss to follow‐up rates were high overall. The highest rates were seen in <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> and <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> (23% and 42% respectively), while the impact was judged as unclear in another two (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> had the lowest rates of losses to follow‐up (14% to 17%). </p> </section> <section id="CD009836-sec-0047"> <h4 class="title">Selective reporting</h4> <p>We considered the risk of selective reporting low in all trials, although only <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> and <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> had pre published protocols. </p> </section> <section id="CD009836-sec-0048"> <h4 class="title">Other potential sources of bias</h4> <p>Other potential sources of bias were considered to be high in all trials. One trial used Zelen randomisation, where participants themselves in one randomisation group (choice‐group) chose whether they preferred an immediate colposcopy or cytological surveillance, which might have created bias towards either direction in terms of later incidence of CIN2+ or CIN3+ lesions (<a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>). All other trials included either a deferred treatment (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>), a colposcopy in addition to cytological surveillance on all follow‐up visits (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>) or had an exit examination with colposcopy regardless of the results of the cytological surveillance at the end of trial (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). This could well have introduced detection bias and over inflated the CIN detection rate in the cytological surveillance arms. We further accounted for this possible source of bias by presenting and meta‐analysing the results without the exit‐examination when possible (18‐month follow‐up window). </p> </section> </section> <section id="CD009836-sec-0049"> <h3 class="title" id="CD009836-sec-0049">Effects of interventions</h3> <p>See: <a href="./full#CD009836-tbl-0001"><b>Summary of findings 1</b> Summary of findings: occurrence of CIN and default rates</a> </p> <section id="CD009836-sec-0050"> <h4 class="title">Primary outcomes</h4> <section id="CD009836-sec-0051"> <h5 class="title">Occurrence of CIN2+</h5> <p>In the majority of the included studies that presented data on more than one time point (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), the incidence of CIN2+ was higher for the immediate colposcopy group at the first time point (before the exit examination at the time of completion), but showed no difference with time (at the time of the trial’s completion) (<a href="#CD009836-tbl-0002">Table 1</a>). <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> revealed differences between the intervention groups for all time points assessed. </p> <p>The meta‐analysis at 18 months (without the exit examination) revealed a difference in the detection of CIN2+ between the two groups (14.3% versus 10.0%, RR 1.50, CI 1.12 to 2.01) with some heterogeneity (P = 0.08, I<sup>2</sup> = 61%), (moderate‐quality evidence). There was no difference at 24 months (17.9% versus 18.3%, RR 1.14, 95% CI 0.66 to 1.97), but there was high inter‐study heterogeneity (P &lt; 0.00001, I<sup>2</sup> = 94%) and presence of other possible bias, resulting in a falsely high CIN detection rate in the cytological surveillance arm, and we considered this to be low‐quality evidence (<a href="./references#CD009836-fig-0007" title="">Analysis 1.1</a>; <a href="#CD009836-fig-0003">Figure 3</a>; <a href="./full#CD009836-tbl-0001">summary of findings Table 1</a>). </p> <div class="figure" id="CD009836-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: occurrence of CIN2+ at different lengths of follow‐up" data-id="CD009836-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: occurrence of CIN2+ at different lengths of follow‐up</p> </div> </div> </div> </section> <section id="CD009836-sec-0052"> <h5 class="title">Occurrence of CIN3+</h5> <p>All the studies assessed the detection rate of CIN3 or worse (CIN3+), although the time point assessed varied. The studies showed conflicting results, as some studies showed an increase in the CIN3+ detection with immediate colposcopy (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>), one found improved detection at 18 months (without the exit examination) but not at 24 months (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>), <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> found no difference, while <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> found no difference at 18 months (without the exit examination), and a higher CIN3+ detection rate for cytological surveillance at 24 months (<a href="#CD009836-tbl-0002">Table 1</a>). </p> <p>The cumulative incidence of CIN3+ was increased after immediate colposcopy when compared to cytological surveillance at 12 months (32% versus 14.0%, RR 2.07, 95% CI 1.54 to 2.79, P = 0.41, I<sup>2</sup> = 0%), but due to other possible bias resulted in a falsely high CIN detection rate in the cytological surveillance arm, although at 18 months (without the exit examination) (7.8% versus 6.9%, (moderate‐quality evidence), 95% CI 0.77 to 1.98) and 24 months (10.3% versus 11.9%, RR 1.02, CI 0.53 to 1.97), this difference was no longer observed. This was mainly driven by the opposing results of a large trial (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>). There was high inter‐study heterogeneity for the comparison at 18 months (P &lt; 0.02, I<sup>2</sup> = 75%) (moderate‐quality evidence), and at 24 months (P &lt; 0.00001, I<sup>2</sup> = 93%). In addition to high heterogeneity the presence of other possible bias probably resulting in a falsely high CIN detection rate in the cytological surveillance arm, meant that we regarded this as low‐quality evidence (<a href="./references#CD009836-fig-0008" title="">Analysis 2.1</a>; <a href="#CD009836-fig-0004">Figure 4</a>; <a href="./full#CD009836-tbl-0001">summary of findings Table 1</a>). </p> <div class="figure" id="CD009836-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: occurence of CIN3+ at different lengths of follow‐up" data-id="CD009836-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: occurence of CIN3+ at different lengths of follow‐up</p> </div> </div> </div> </section> </section> <section id="CD009836-sec-0053"> <h4 class="title">Secondary outcomes</h4> <section id="CD009836-sec-0054"> <h5 class="title">Incidence of other CIN grades at histology</h5> <section id="CD009836-sec-0055"> <h6 class="title">Occurrence of histologically proven HPV or koilocytic atypia</h6> <p>One study assessed this at 6, 12 and 24 months (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>) and another at 24 months of surveillance (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> reported a lower rate of HPV‐associated histological changes for immediate colposcopy as compared to six‐month cytological surveillance (9% versus 17%, RR 0.52, 95% CI 0.28 to 0.95) but no difference was observed at 12 or 24 months. Interestingly, <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> identified a higher rate for women attending for immediate colposcopy, as opposed to repeat cytology (50.5% versus 33.3%, RR 1.52, 95% CI 1.17 to 1.96) (<a href="#CD009836-tbl-0002">Table 1</a>). </p> <p>The meta‐analysis revealed that immediate referral to colposcopy increased the detection of clinically non‐significant infections as opposed to repeat cytology at 24 months (32% versus 21%, RR 1.49, 95% CI 1.17 to 1.90) (<a href="./references#CD009836-fig-0012" title="">Analysis 4.1</a>). There was no evident inter‐study heterogeneity (P = 0.69, I<sup>2</sup> = 0%), but due to other possible bias resulting in a falsely high CIN detection rate in the cytological surveillance arm, we regarded this as moderate‐quality evidence. </p> </section> <section id="CD009836-sec-0056"> <h6 class="title">Occurrence of any CIN</h6> <p>Three studies provided data on the rates of any CIN grade (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> provided data for cytological surveillance at 6, 12 and 24 months, <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> at 12 months and <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> at 24 months. All individual studies demonstrated that women undergoing immediate colposcopy had a higher rate of detected CIN of any grade (<a href="#CD009836-tbl-0002">Table 1</a>). </p> <p>The meta‐analysis confirmed that the cumulative incidence of any grade of CIN was higher among women referred to immediate colposcopy (12 months: RR 1.72, 95% CI 1.09 to 2.70; 24 months: RR 2.02, 95% CI 1.33 to 3.08). Considerable heterogeneity was present at both time points (P = 0.001, I<sup>2</sup> = 91% and P = 0.02, I<sup>2</sup> = 82%, respectively) and due to other possible bias resulting in falsely high CIN detection rates in the cytological surveillance arm, we regarded this as low‐quality evidence (<a href="./references#CD009836-fig-0009" title="">Analysis 3.1</a>; <a href="./references#CD009836-fig-0012" title="">Analysis 4.1</a>; <a href="./full#CD009836-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD009836-sec-0057"> <h6 class="title">Occurrence of CIN1</h6> <p>One study that assessed the rate of CIN1 at six and 12 months suggested no difference between immediate colposcopy and cytological surveillance (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>) (<a href="#CD009836-tbl-0002">Table 1</a>). Two studies assessed the occurrence of CIN1 rate at 24 months (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>), both of which suggested a higher rate of detection of low‐grade disease in the immediate colposcopy group (<a href="#CD009836-tbl-0002">Table 1</a>). </p> <p>The meta‐analysis revealed at least double the rate of CIN1 detection when women underwent colposcopy immediately as opposed to repeat cytology (21% versus 8%, RR 2.58, 95% CI 1.69 to 3.94), suggesting that immediate colposcopy may have increased the detection of clinically insignificant lesions (<a href="./references#CD009836-fig-0012" title="">Analysis 4.1</a>). There was no evident inter‐study heterogeneity (P = 0.81, I<sup>2</sup> = 0%), but due to other possible bias resulting in a falsely high CIN detection rate in the cytological surveillance arm we regarded this as moderate‐quality evidence. </p> </section> <section id="CD009836-sec-0058"> <h6 class="title">Occurrence of CIN2</h6> <p>Four studies assessed the incidence of CIN2 (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>); one reported results at 6 and 12 months (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>), two (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>) at 18 months (without the exit examination), three (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>) at 24 months and one (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) at 30 and 36 months. The rate of CIN2 was higher in the immediate colposcopy group in the majority of the studies, apart from one (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). The difference in CIN2 rate detection was higher at 18 months rather than at 24 months in <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> and similarly at 30 months as opposed to 36 months in <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> (<a href="#CD009836-tbl-0002">Table 1</a>). </p> <p>The overall rate of CIN2 in the meta‐analysis was higher for the immediate colposcopy group at 18 months (6.5% versus 3.2%, RR 2.04, CI 1.52 to 2.73) with low heterogeneity (P = 0.46, I<sup>2</sup>= 0%); high‐quality evidence (<a href="./references#CD009836-fig-0013" title="">Analysis 5.1</a>; <a href="#CD009836-fig-0005">Figure 5</a>). There was no evident difference at 24 months of surveillance (7.6% versus 5.4%, RR 1.45, 95% CI 0.87 to 2.40); there was considerable inter‐study heterogeneity (P = 0.009, I<sup>2</sup>= 74%), and additionally, due to the presence of other possible bias resulting in a falsely high CIN detection rate in the cytological surveillance arm, this was regarded as low‐quality evidence. </p> <div class="figure" id="CD009836-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: occurence of CIN2 at different lengths of follow‐up" data-id="CD009836-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: occurence of CIN2 at different lengths of follow‐up</p> </div> </div> </div> <p>In total there were 18 cases of invasive cervical cancer, seven in immediate colposcopy and 11 in cytological surveillance groups: one case of stage 1A1 cervical cancer in the deferred treatment group detected by cytological smear in <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>, three cases of invasive cervical cancer in both immediate colposcopy and cytological surveillance groups in <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> and four cases of invasive disease in immediate colposcopy and seven in the cytological surveillance group in <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>. There were no cases of invasive cancer in the two other included trials (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>). </p> </section> </section> <section id="CD009836-sec-0059"> <h5 class="title">Default rates</h5> <p>All five included trials reported on the non‐compliance rates for immediate colposcopy versus cytological surveillance (<a href="#CD009836-tbl-0002">Table 1</a>). Two reported non‐attendance rates at six and 12 months (<a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), two at 24 months (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>) and one for all the time points (6, 12 and 24 months) (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). The risk of non‐compliance was significantly greater for the repeat cytology arm and increased with the length of the follow‐up. <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>, the largest study and one with high methodological quality, reported an almost double risk of default for women followed up in the community when compared to those referred to immediate colposcopy (6 months: RR 1.88, 95% CI 1.56 to 2.27; 12 months: RR 2.16, 95% CI 1.80 to 2.59) (<a href="#CD009836-tbl-0002">Table 1</a>). The magnitude of effect was much greater in the remaining trials. In <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> the RR for cumulative risk of default at 24 months was up to 27.42 (95% CI 10.17 to 73.93) for the surveillance arm at the exit exam, as opposed to the immediate colposcopy group (<a href="#CD009836-tbl-0002">Table 1</a>). The study setting and protocols varied greatly between the included trials, which could well explain the observed differences in default rates between studies. </p> <p>The meta‐analysis suggested that the risk for non‐compliance was higher for the repeat cytology group with a four‐fold increase at 6 months, a six‐fold increase at 12 months and a 19‐fold increase at 24 months (6 months: RR 3.85, 95% CI 1.27 to 11.63; 12 months: RR 6.60, 95% CI 1.49 to 29.29; 24 months: RR 19.1 95% CI 9.02 to 40.43). The inter‐study heterogeneity was considerable for the analysis at six and 12 months (P = 0.02, I<sup>2</sup> = 76% and P &lt; 0.0004, I<sup>2</sup> = 87%, respectively), and we therefore regarded this as moderate‐quality evidence, whereas we considered the evidence to be of high quality at 24 months (<a href="./references#CD009836-fig-0014" title="">Analysis 6.1</a>; <a href="#CD009836-fig-0006">Figure 6</a>; <a href="./full#CD009836-tbl-0001">summary of findings Table 1</a>). </p> <div class="figure" id="CD009836-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: default rates at different lengths of follow‐up" data-id="CD009836-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: default rates at different lengths of follow‐up</p> </div> </div> </div> </section> <section id="CD009836-sec-0060"> <h5 class="title">Presence of after‐effects</h5> <p><a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> was the only study that reported on the incidence of after‐effects based on a questionnaire completed six weeks after immediate colposcopy or the first cytological follow‐up smear. Pain, bleeding, or vaginal discharge were all more common after immediate colposcopy than after cytology (<a href="#CD009836-tbl-0002">Table 1</a>). </p> </section> <section id="CD009836-sec-0061"> <h5 class="title">Presence of anxiety, distress or depression</h5> <p>Both <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> and <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> reported incidence of psychosocial morbidity in the randomisation groups (<a href="#CD009836-tbl-0002">Table 1</a>). In <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>, the authors reported the incidence of anxiety and depression at six weeks, and thereafter at six‐month intervals until 30 months of surveillance. Anxiety, measured as score of 11 or more on the Hospital Anxiety and Depression anxiety sub scale, was less common in the immediate colposcopy group compared to the cytological surveillance group at six weeks (RR 0.58, 95% CI 0.43 to 0.79). There was no difference between the randomisation groups thereafter. Incidence of depression, defined as a score of 8 or more on the Hospital Anxiety and Depression Scale (HADS) (<a href="./references#CD009836-bbs2-0068" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavia1983;67:361-70.">Zigmond 1983</a>), did not differ between the two groups throughout the follow‐up period. <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> used the General Health Questionnaire (GHQ)‐caseness (<a href="./references#CD009836-bbs2-0020" title="BridgesKW , GoldbergDP . The validation of the GHQ-28 and the use of the MMSE in neurological in-patients. British Journal of Psychiatry1986;148:548-53.">Bridges 1986</a>) (defined as a score of 4 or above) to measure the presence of anxiety or distress. There were no differences between choice and no‐choice arms at baseline or after six and 12 months of surveillance. Given the differences in the comparison groups and the assessment methods, a meta‐analysis was not possible. </p> </section> </section> <section id="CD009836-sec-0062"> <h4 class="title">Subgroup analyses</h4> <p>The optimum management option may be different for women found to have ASCUS (borderline) or LSIL cytology (mild dyskaryosis) in the baseline smear. We were unable to perform a subgroup analysis for women with ASCUS cytology as only one study (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) presented this separately. We could extract separate data for women referred with LSIL cytology only from two studies (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>). These studies reported on the incidence of CIN2, CIN2+ and CIN3+ or worse at 24 months. </p> <p>The incidence of the above histological outcomes was higher for immediate colposcopy as opposed to cytology, although based on small sample size (CIN2: 8.4% versus 11.6%, RR 1.72, 95% CI 0.66 to 4.48; CIN2+: 23.4% versus 27.5%, RR 1.43, 95% CI 0.51 to 4.01: CIN3+: 15% versus 15.9%, RR 1.24, 95% CI 0.39 to 3.94); all analyses demonstrated inter‐study heterogeneity (P &lt; 0.01, I<sup>2</sup> &gt; 75%) and presented moderate‐quality evidence (<a href="./references#CD009836-fig-0015" title="">Analysis 7.1</a>). </p> <p><a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> revealed opposing direction of effect to the other included studies in some of the outcomes assessed. We performed a subgroup analysis that excluded this trial after 24 months of surveillance and found little or no difference in the rate of CIN2 and CIN2+ between the immediate colposcopy and cytological surveillance groups: CIN2 (RR 1.54, 95% CI 0.41 to 5.78, P = 0.02, I<sup>2</sup>= 83%) and for CIN2+ (RR 1.72, 95% CI 0.86 to 3.47, P = 0.004, I<sup>2</sup> = 88%; moderate‐quality evidence). Immediate colposcopy increased the detection of CIN3+ as opposed to cytological surveillance (30.9% versus 17%, RR 1.80, 95% CI 1.11 to 2.92, heterogeneity: P = 0.10, I<sup>2</sup>= 62%; high‐quality evidence) (<a href="./references#CD009836-fig-0016" title="">Analysis 8.1</a>; <a href="./references#CD009836-fig-0017" title="">Analysis 8.2</a>; <a href="./references#CD009836-fig-0018" title="">Analysis 8.3</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009836-sec-0063" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009836-sec-0063"></div> <section id="CD009836-sec-0064"> <h3 class="title" id="CD009836-sec-0064">Summary of main results</h3> <p>The results of this meta‐analysis suggest that the difference in the CIN2 or CIN2+ rate detection was higher for the immediate colposcopy group at 18 months (without the exit examination), but this was no longer the case at 24 months. Although this suggests that colposcopy may allow earlier diagnosis of CIN2 lesions that cytology would require longer to detect, it may also be explained by the trials’ design. All participants in the cytological surveillance arms underwent exit examination, a colposcopy with or without treatment, irrespective of their cytological status in all trials. This ‘artificial’ detection of cases of high‐grade disease at completion would plausibly be lower in a ‘real‐life’ setting in the cytological surveillance arm; this may over inflate the reliability of repeat cytology to detect high‐grade disease. </p> <p>Although the evidence suggests that there may be little or no difference in the rate of CIN3+ detection at 24 months between the two arms, this result was mainly driven by a large RCT (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) with almost opposing results to the remaining RCTs (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). The ALTS study had a different design in that all women randomised and analysed in the cytological surveillance arm had a repeat smear that was assessed by an expert cytopathologist at recruitment. Almost 40% of CIN3+ lesions in the cytology arm were detected during this repeat cytology smear and this may have inflated the ability of cytology to detect disease when compared to immediate colposcopy (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>). After exclusion of this trial, the difference of CIN3+ detection favoured immediate colposcopy. </p> <p>Women attending for immediate colposcopy after a single LSIL or ASCUS smear were 50% more likely to have clinically insignificant HPV infections detected. The rates of histologically detected lesions associated with HPV infection were lower for the repeat cytology group, possibly explained by spontaneous regression of clinically insignificant lesions during cytological surveillance. Similarly, there was an increase in the detection of CIN1 lesions, supporting the perception that immediate colposcopy may increase the risk of over‐intervention and over‐treatment, by detection of insignificant lesions that would otherwise spontaneously revert to normal over time. </p> <p>The evidence suggests that the risk for default to follow‐up was probably higher for the repeat cytology group at 6, 12 and 24 months. The difference between the two groups changed from four‐fold at 6 months and six‐fold at 12 months up to 19‐fold at 24 months. The point estimate at 24 months could well be biased and over‐inflated due to selection of studies at that follow‐up window, that is, lack of data from one study (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) and inclusion of another with a very different trial setting (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>). Compliance with follow‐up still appeared to decline with time and women may be at increased risk of invasion due to underlying occult high‐grade disease. The inter‐study heterogeneity was significant, possibly due to differences in the magnitude of the default rates in the immediate colposcopy group between different trials. These differences may be explained by differences in the design and randomisation process that could increase (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>: randomisation and admittance to either colposcopy or cytological surveillance after HPV test results) or decrease (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>: immediate colposcopy preferably on the same day) the risk of non‐compliance in the immediate colposcopy arm. Only one study reported on the after‐effects ‐ pain, bleeding or vaginal discharge ‐ and found that these were significantly more common after immediate colposcopy (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). Meta‐analysis of the after‐effects and anxiety and depression was not possible. </p> </section> <section id="CD009836-sec-0065"> <h3 class="title" id="CD009836-sec-0065">Overall completeness and applicability of evidence</h3> <p>This is the first meta‐analysis that comprehensively investigates the value of immediate colposcopy versus cytological surveillance in women with lesions of equivocal significance in the absence of HPV test. A previous systematic review only included three small RCTs (<a href="./references#CD009836-bbs2-0042" title="KyrgiouM , KoliopoulosG , Martin-HirschP , KehoeS , FlannellyG , MitrouS , et al. Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature. Cancer Treatment Reviews2007;33:514-20.">Kyrgiou 2007a</a>). Two large trials, one from the US (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>) and the other from the UK (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) addressed this comparison comprehensively with large sample sizes. Because all included studies were conducted in high‐income setting, the applicability of the evidence to lower income settings is not clear. This systematic review still provides a comprehensive review of the existing literature and meta‐analytical pooling that will allow clinicians to evaluate the trade‐off between the risk of detection of insignificant lesions versus the risk of poor compliance and non‐detection of occult high‐grade disease. </p> </section> <section id="CD009836-sec-0066"> <h3 class="title" id="CD009836-sec-0066">Quality of the evidence</h3> <p>All of the included studies were RCTs, however, our analysis has several limitations and the results should be interpreted with caution. There are only a small number of included studies, two of which included a comparatively large number of participants (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>), which may account for some of the heterogeneity that was observed and which was considerable or substantial in many of the comparisons. It was this high heterogeneity, as well as the presence of bias from study design possibly resulting in falsely high CIN detection rate in the cytological surveillance arm in the 24‐month follow‐up window, that accounted for the down‐grading of the evidence to 'moderate' or 'low' in several cases following the GRADE assessment. Several of the included studies varied in their design and comparison groups, with the presence of exit examination and the length of follow‐up. <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>, for example, had a choice and non‐choice arm, <a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a> performed a repeat cytology at recruitment in the cytology surveillance arm, while one of the older studies (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>) performed a treatment for all participants at completion. For many of the explored outcomes and comparisons, there was substantial heterogeneity, possibly explained by the difference in the studies’ design. </p> <p>The results presented in the individual trials are those derived from women who completed the given period of surveillance as the presence or absence of disease cannot be verified in those women who defaulted from surveillance. Furthermore, all the included studies, apart from <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>, performed exit examinations at the time of the study completion for both arms, some of which included an excision of the transformation zone for all subjects (<a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>). The comparison of the rates of different grades of disease at the time of the study completion may represent an ‘artificial’ detection of lesions that would not have been detected in the cytology arm in a ‘real‐life’ setting, with the risk to inflate the ability of repeat cytology to detect disease. We therefore considered the quality of evidence in the 24‐month follow‐up window to be low. </p> <p>Most of the included studies did not assess the impact of age of the population in the preferred management approach. Only <a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a> assessed the effect of age on histological outcomes and concluded that the difference in cumulative incidence of CIN2+ between the trial arms was more pronounced amongst younger women (20 to 39 years), as opposed to older women (40 to 59 years). Furthermore, in younger women (age 20 to 39 years) the risk ratios for CIN2 or worse were markedly higher than CIN3 or worse. </p> </section> <section id="CD009836-sec-0067"> <h3 class="title" id="CD009836-sec-0067">Potential biases in the review process</h3> <p>All of the included studies were RCTs. It was not possible to blind participants and personnel given the nature of the intervention. The random sequence generation was considered appropriate in all studies and the allocation concealment in all but one study (<a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>), where the allocation concealment process was not described in full. Only one study (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>) described blinding of assessors; the colposcopist was blinded at exit examination only with regards to the women's cytology status, randomisation category and any clinical outcomes. The lack of assessor blinding in the other included studies (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>; <a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a>; <a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a>; <a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a>) may have introduced a degree of detection bias. Loss to follow‐up rates were high overall ranging from 14% to 42%, which may have introduced a degree of attrition bias. The risk of selective reporting was considered low in all trials. </p> <p>In order to minimise bias whilst undertaking the review, two review authors (MK and IK) independently reviewed the retrieved citations and the extracted data. There was no discrepancy in the included studies; some minor discrepancies in the data extraction were resolved with discussion and the involvement of a third reviewer (MA) if necessary. </p> </section> <section id="CD009836-sec-0068"> <h3 class="title" id="CD009836-sec-0068">Agreements and disagreements with other studies or reviews</h3> <p>Almost one in ten women screened in the UK will have a minor lesion detected in her smear. Several authorities recommend conservative surveillance in the primary care setting, as spontaneous regression of most of these lesions will occur (<a href="./references#CD009836-bbs2-0042" title="KyrgiouM , KoliopoulosG , Martin-HirschP , KehoeS , FlannellyG , MitrouS , et al. Management of minor cervical cytological abnormalities: a systematic review and a meta-analysis of the literature. Cancer Treatment Reviews2007;33:514-20.">Kyrgiou 2007a</a>). Referral to colposcopy may increase psychological morbidity for these women who experience similar levels of anxiety to those referred with high‐grade disease (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). This increase in anxiety appears to be transient and is no different after six weeks. Furthermore, further investigation of lesions that were deemed to regress without intervention increases the risk of over‐intervention and over‐treatment with subsequent possible adverse reproductive sequale (<a href="./references#CD009836-bbs2-0011" title="ArbynM , KyrgiouM , SimoensC , RaifuAO , KoliopoulosG , Martin-HirschP , et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ2008;337:a1284.">Arbyn 2008</a>; <a href="./references#CD009836-bbs2-0031" title="FountaC , ArbynM , ValasoulisG , KyrgiouM , TsiliA , Martin-HirschP , et al. Proportion of excision and cervical healing after large loop excision of the transformation zone for cervical intraepithelial neoplasia. BJOG: An International Journal of Obstetrics and Gynaecology2010;117:1468-74.">Founta 2010</a>; <a href="./references#CD009836-bbs2-0041" title="KyrgiouM , KoliopoulosG , Martin-HirschP , ArbynM , PrendivilleE , ParaskevaidisE . Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet2006;367(9509):489-98.">Kyrgiou 2006</a>;<a href="./references#CD009836-bbs2-0044" title="KyrgiouM , ArbynM , Martin-HirschP , ParaskevaidisE . Increased risk of preterm birth after treatment for CIN. BMJ2012;345:e5847.">Kyrgiou 2012a</a>; <a href="./references#CD009836-bbs2-0045" title="KyrgiouM , MitraA , ArbynM , StasinouSM , Martin-HirschP , BennettP , et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ2014;349:g6192.">Kyrgiou 2014</a>;<a href="./references#CD009836-bbs2-0046" title="KyrgiouM , ValasoulisG , StasinouSM , FountaC , AthanasiouA , BennettP , et al. Proportion of cervical excision for cervical intraepithelial neoplasia as a predictor of pregnancy outcomes. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics2015;128:141-7.">Kyrgiou 2015</a>; <a href="./references#CD009836-bbs2-0047" title="KyrgiouM , AthanasiouA , ParaskevaidiM , MitraA , KallialaI , Martin-HirschP , et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis. BMJ2016;354:i3633.">Kyrgiou 2016a</a>). The opponents supporting immediate assessment with colposcopy emphasise that protracted attendance for repeat cytology decreases with time (<a href="./references#CD009836-bbs2-0063" title="SoutterWP , MossB , PerrymanK , KyrgiouM , PapakonstantinouK , Ghaem-MaghamiS . Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia. Acta Obstetrics and Gynecology Scandinavica2012;91:1103-8.">Soutter 2012</a>) and this was also confirmed in this analysis. The evidence suggests that approximately one third of women referred with borderline or low‐grade cytological abnormalities have an occult high‐grade disease and non‐compliance with surveillance may put some women at risk of developing invasive disease (<a href="./references#CD009836-bbs2-0018" title="BolgerBS , LewisBV . A prospective study of colposcopy in women with mild dyskaryosis or koilocytosis. British Journal of Obstetrics and Gynaecology1988;95(11):1117-9.">Bolger 1988</a>; <a href="./references#CD009836-bbs2-0023" title="Contreras-MelendezL , HerbertA , Millward-SadlerGH , MooreIE , MassonGM , CamillieriAP , et al. Assessment of the accuracy of cytology in women referred for colposcopy and biopsy: the results of a 1 year audit. Cytopathology1992;3(5):267-74.">Contreras‐Melendez 1992</a>; <a href="./references#CD009836-bbs2-0032" title="GilesJA , DeeryA , CrowJ , WalkerP . The accuracy of repeat cytology in women with mildly dyskaryotic smears. British Journal of Obstetrics and Gynaecology1989;96(9):1067-70.">Giles 1989</a>; <a href="./references#CD009836-bbs2-0056" title="ParaskevaidisE , KaponisA , Malamou-MitsiV , DavidsonEJ , HirschPM , KoliopoulosG , et al. The natural history of HPV infection of the uterine cervix. Long-term observational and histological data. Anticancer Research2002;22(2B):1177-81.">Paraskevaidis 2002</a>; <a href="./references#CD009836-bbs2-0062" title="SoutterWP , WisdomS , BroughAK , MonaghanJM . Should patients with mild atypia in a cervical smear be referred for colposcopy?British Journal of Obstetrics and Gynaecology1986;93(1):70–4.">Soutter 1986</a>; <a href="./references#CD009836-bbs2-0067" title="WalkerEM , DodgsonJ , DuncanID . Does mild atypia on a cervical smear warrant further investigation?Lancet1986;2(8508):672-3.">Walker 1986</a>). The participants lost to follow‐up due to poor compliance in these trials could result in an underestimation of the true number of high‐grade lesions that were missed in the cytology group. </p> <p>The financial implications of the two approaches to health services should also be considered. Cost‐effectiveness analysis in some of the earlier studies suggested that referral to colposcopy is a more cost‐effective alternative to repeat cytology (<a href="./references#CD009836-bbs2-0030" title="FlannellyG , CampbellMK , MeldrumP , TorgersonDJ , TempletonA , KitchenerHC . Immediate colposcopy or cytological surveillance for women with mild dyskaryosis: a cost effectiveness analysis. Journal of Public Health Medicine1997;19(4):419-23.">Flannelly 1997</a>; <a href="./references#CD009836-bbs2-0036" title="JohnsonN , SuttonJ , ThorntonJG , LilfordRJ , JohnsonVA , PeelKR . Decision analysis for best management of mildly dyskaryotic smear. Lancet1993;342:91-6.">Johnson 1993</a>). The cost‐effectiveness analysis of the TOMBOLA trial suggested no difference amongst the two approaches although cytological surveillance was less costly (<a href="./references#CD009836-bbs2-0005" title="CottonS , SharpL , LittleJ , CruickshankM , SethR , SmartL , et al, Trial Of Management of Borderline and Other Low/grade Abnormal Smears Group. The role of human papillomavirus testing in the management of women with low/grade abnormalities: multicentre randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology2010;117(6):645-59. CottonSC , SharpL , LittleJ , DuncanI , AlexanderL , CruickshankME , et al for TOMBOLA group. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemporary Clinical Trials2006;27(5):449-71. GurumurthyM , CottonSC , SharpL , SmartL , LittleJ , WaughN , et al. Postcolposcopy management of women with histologically proven CIN 1: results from TOMBOLA. Journal of Lower Genital Tract Disease2014;18(3):203-9. SharpL , CottonS , CarsinAE , GrayN , ThorntonA , CruickshankM , et al for TOMBOLA Group. Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the Trial Of Management of Borderline and Other Low-grade Abnormal smears (TOMBOLA). Psycho-oncology2013;22(2):368-80. SharpL , CottonS , CruickshankM , GrayNM , HarrildK , SmartL , et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. Journal of Lower Genital Tract Disease2014;18(2):142-50. SharpL , CottonS , LittleJ , GrayNM , CruickshankM , SmartL , et al. Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the tombola randomised controlled trial. PloS one2013;8(12):e80092. SharpL , CottonS , ThorntonA , GrayN , CruickshankM , WhynesD , et al. Who defaults from colposcopy? A multi-centre, population-based, prospective cohort study of predictors of non-attendance for follow-up among women with low-grade abnormal cervical cytology. European Journal of Obstetrics, Gynecology, and Reproductive Biology2012;165(2):318-25. TOMBOLA Group. Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. BMJ2009;339:b2548. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ2009;339:2546. TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ2009;339:b2549. WhynesDK , WoolleyC , PhilipsZ , for TOMBOLA Group. Management of low-grade cervical abnormalities detected at screening: which method do women prefer?Cytopathology2008;19(6):355-62. ">TOMBOLA 2009</a>). The ALTS trial suggested that HPV‐triage or repeat cytology of a single repeat smear was cost‐effective, although there was no difference in cost‐effectiveness if two or more smears were performed (<a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a>). The cost‐effectiveness of the two approaches largely depends on the policy of subsequent surveillance in the case of negative colposcopy; this was not addressed in any of the included studies. </p> <p>Strong evidence supports the preferential use of HPV test particularly in the triage of women with ASCUS (borderline) cytology (<a href="./references#CD009836-bbs2-0008" title="ArbynM , BuntinxF , Van RanstM , ParaskevaidisE , Martin-HirschJ, DillnerJ . Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. Journal of the National Cancer Institute2004;96(4):280-93.">Arbyn 2004</a>; <a href="./references#CD009836-bbs2-0014" title="ArbynM , RoncoG , AnttilaA , MeijerCJ , PoljakM , OgilvieG , et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine2012;30 Suppl 5:F88-99.">Arbyn 2012</a>; <a href="./references#CD009836-bbs2-0015" title="ArbynM , RoelensJ , SimoensC , BuntinxF , ParaskevaidisE , Martin-HirschPPL , et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD008054.pub2]">Arbyn 2013a</a>) that would benefit from colposcopy as a more accurate and cost‐effective modality. Its value is less pronounced in younger women below the age of 30 and women with LSIL (mild dyskaryosis) (<a href="./references#CD009836-bbs2-0012" title="ArbynM , Martin-HirschP , BuntinxF , Van RanstM , ParaskevaidisE , DillnerJ . Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. Journal of Cellular and Molecular Medicine2009;13:648-59.">Arbyn 2009</a>; <a href="./references#CD009836-bbs2-0015" title="ArbynM , RoelensJ , SimoensC , BuntinxF , ParaskevaidisE , Martin-HirschPPL , et al. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions. Cochrane Database of Systematic Reviews2013, Issue 3. [DOI: 10.1002/14651858.CD008054.pub2]">Arbyn 2013a</a>). However, this test is not always readily available, particularly in low‐resource settings. In Europe alone, one in ten women with ASCUS cytology and four in ten women with LSIL will not have a triage HPV test and clear recommendations are required to manage such cases. Newer markers such as mRNA or p16/Ki67 immunostaining have more recently shown promising results claiming an equal sensitivity to that of the DNA test but with improved specificity in this setting (<a href="./references#CD009836-bbs2-0016" title="ArbynM , RoelensJ , CuschieriK , CuzickJ , SzarewskiA , RatnamS , et al. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy. International Journal of Cancer2013;132:101-8.">Arbyn 2013b</a>; <a href="./references#CD009836-bbs2-0052" title="NasioutzikiM , DaniilidisA , DinasK , KyrgiouM , ValasoulisG , LoufopoulosPD , et al. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples. International Journal of Gynecological Cancer2011;21:79-85.">Nasioutziki 2011</a>; <a href="./references#CD009836-bbs2-0065" title="TsoumpouI , ArbynM , KyrgiouM , WentzensenN , KoliopoulosG , Martin-HirschP , et al. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treatment Reviews2009;35:210-20.">Tsoumpou 2009</a>; <a href="./references#CD009836-bbs2-0066" title="TsoumpouI , ValasoulisG , FountaC , KyrgiouM , NasioutzikiM , DaponteA , et al. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study. Gynecologic Oncology2011;121(1):49-53.">Tsoumpou 2011</a>). Further combinations of novel biomarkers and Clinical Decision Support Scoring Systems (DSSS) based on mathematical modelling that will create user‐friendly tools have the potential to further improve the management of this population (<a href="./references#CD009836-bbs2-0019" title="BountrisP , HaritouM , PouliakisA , MargariN , KyrgiouM , SpathisA , et al. An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection. BioMed Research International2014;2014:341483.">Bountris 2014</a>; <a href="./references#CD009836-bbs2-0037" title="KarakitsosP , PouliakisA , MeristoudisC , MargariN , KassanosD , KyrgiouM , et al. A preliminary study of the potential of tree classifiers in triage of high-grade squamous intraepithelial lesions. Analytical and quantitative cytology and histology/The International Academy of Cytology [and] American Society of Cytology2011;33:132-40.">Karakitsos 2011</a>; <a href="./references#CD009836-bbs2-0038" title="KarakitsosP , ChreliasC , PouliakisA , KoliopoulosG , SpathisA , KyrgiouM , et al. Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers. Journal of Biomedicine &amp; Biotechnology2012;2012:303192.">Karakitsos 2012</a>; <a href="./references#CD009836-bbs2-0048" title="KyrgiouM , PouliakisA , PanayiotidesJG , MargariN , BountrisP , ValasoulisG , et al. Personalised management of women with cervical abnormalities using a clinical decision support scoring system. Gynecological Oncology2016;141:29–35.">Kyrgiou 2016b</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009836-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD009836-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD009836-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: occurrence of CIN2+ at different lengths of follow‐up" data-id="CD009836-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: occurrence of CIN2+ at different lengths of follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: occurence of CIN3+ at different lengths of follow‐up" data-id="CD009836-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: occurence of CIN3+ at different lengths of follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: occurence of CIN2 at different lengths of follow‐up" data-id="CD009836-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: occurence of CIN2 at different lengths of follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: default rates at different lengths of follow‐up" data-id="CD009836-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: default rates at different lengths of follow‐up</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Occurence of CIN2+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN2+" data-id="CD009836-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Occurence of CIN2+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN2+ </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Occurence of CIN3+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN3+" data-id="CD009836-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Occurence of CIN3+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN3+ </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 1: Presence of any CIN in histology at 12 months" data-id="CD009836-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 1: Presence of any CIN in histology at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 2: Presence of CIN1/2 in histology at 12 months" data-id="CD009836-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 2: Presence of CIN1/2 in histology at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 3: Presence of CIN3+ in histology at 12 months" data-id="CD009836-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Histology at 12 months: immediate colposcopy versus cytological surveillance, Outcome 3: Presence of CIN3+ in histology at 12 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Histology at 24 months: immediate colposcopy versus cytological surveillance, Outcome 1: Histology at 24 months" data-id="CD009836-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Histology at 24 months: immediate colposcopy versus cytological surveillance, Outcome 1: Histology at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Occurence of CIN2 at different lengths of follow‐up: Immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN2" data-id="CD009836-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Occurence of CIN2 at different lengths of follow‐up: Immediate colposcopy versus cytological surveillance, Outcome 1: Occurrence of CIN2 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Default rates: immediate colposcopy versus cytological surveillance, Outcome 1: Default rates" data-id="CD009836-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Default rates: immediate colposcopy versus cytological surveillance, Outcome 1: Default rates </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Histology at 24 months: immediate colposcopy versus cytological surveillance, LSIL/mild dyskaryosis only, Outcome 1: CIN incidence at 24 months, after LSIL/mild dyskaryosis at baseline" data-id="CD009836-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Histology at 24 months: immediate colposcopy versus cytological surveillance, LSIL/mild dyskaryosis only, Outcome 1: CIN incidence at 24 months, after LSIL/mild dyskaryosis at baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 1: Presence of CIN2 in histology at 24 months" data-id="CD009836-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 1: Presence of CIN2 in histology at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 2: Presence of CIN2+ in histology at 24 months" data-id="CD009836-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 2: Presence of CIN2+ in histology at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009836-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/urn:x-wiley:14651858:media:CD009836:CD009836-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 3: Presence of CIN3+ in histology at 24 months" data-id="CD009836-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_t/tCD009836-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial, Outcome 3: Presence of CIN3+ in histology at 24 months </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/media/CDSR/CD009836/image_n/nCD009836-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009836-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: occurrence of CIN and default rates</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Immediate colposcopy compared with cytological surveillance for minor cervical cytological abnormalities: occurrence of different grades CIN in histology according to follow‐up time and default rates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with ASCUS or LSIL </p> <p><b>Settings:</b> colposcopy clinic </p> <p><b>Intervention:</b> immediate colposcopy </p> <p><b>Comparison:</b> cytological surveillance </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with cytological surveillance</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with immediate colposcopy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN2+ in histology at 18 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>101 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>151 per 1000</b><br/>(113 to 203) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.50</b> (1.12 to 2.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4028<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN2+ in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>183 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>209 per 1000</b><br/>(121 to 361) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.14</b> (0.66 to 1.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4331<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN3+ in histology at 18 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>69 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>86 per 1000</b><br/>(53 to 137) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.24</b> (0.77 to 1.98) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4028<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/><b>moderate<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of CIN3+ in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>119 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>121 per 1000</b><br/>(63 to 234) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.02</b> (0.53 to 1.97) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4331<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>3,5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Occurrence of any CIN in histology at 24 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>316 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>639 per 1000</b><br/>(420 to 974) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 2.02</b> (1.33 to 3.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>656<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/><b>low<sup>3,8</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Default rates at 6 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b><br/>(80 to 728) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.85</b><br/>(1.27 to 11.63) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5117<br/>(3 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>moderate<sup>6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Default rates at 12 months</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>413 per 1000</b><br/>(93 to 1000) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 6.60</b><br/>(1.49 to 29.29 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5115<br/>(3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝</p> <p><b>moderate<sup>7</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). For default rates the relative effect is calculated between cytological surveillance versus immediate colposcopy. For histology the relative effect is calculated between immediate colposcopy versus cytological surveillance.<br/><b>ASCUS</b> : atypical squamous cells of undetermined significance <b>CI:</b> Confidence interval; <b>CIN</b> : cervical intraepithelial neoplasia; <b>LSIL</b> : low‐grade squamous intra‐epithelial lesions; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded to moderate due to substantial inter‐study heterogeneity (P = 0.08, I<sup>2</sup>= 61%).<br/><sup>2</sup> Downgraded to low due to considerable inter‐study heterogeneity (P &lt; 0.00001, I<sup>2</sup>= 94%).<br/><sup>3</sup> Downgraded due to presence of the other possible bias resulting in falsely high CIN detection rate in the cytological surveillance arm.<br/><sup>4</sup> Downgraded to moderate due to substantial inter‐study heterogeneity (P = 0.02, I<sup>2</sup>= 75%).<br/><sup>5</sup> Downgraded to low due to considerable inter‐study heterogeneity (P &lt; 0.00001, I<sup>2</sup>= 93%).<br/><sup>6</sup> Downgraded to moderate due to considerable inter‐study heterogeneity (P = 0.02, I<sup>2</sup>= 76%).<br/><sup>7</sup> Downgraded to moderate due to considerable inter‐study heterogeneity (P = 0.0004, I<sup>2</sup>= 87%).<br/><sup>8</sup> Downgraded to low due to substantial inter‐study heterogeneity (P = 0.02, I<sup>2</sup> = 82%). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings: occurrence of CIN and default rates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009836-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reported individual outcomes in the included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Immediate colposcopy</b> </p> <p><b>n/N (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cytological surveillance</b> </p> <p><b>n/N (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR + 95% CI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a><b>(ASCUS)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months<sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/1163 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/1164 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 [1.49, 3.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/1163 (10.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92/1164 (7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 [1.00, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/1163 (5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/1164 (5.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.62, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/1163 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/1164 (5.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.02 [0.72,1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/1163 (10.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/1164 (14.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71 [0.57, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/1163 (5.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108/1164 (9.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54 [0.39, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15/1163 (1.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>165/1164 (14.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.99 [6.52, 18.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0001" title="KulasingamSL , KimJJ , LawrenceWF , MandelblattJS , MyersER , SchiffmanM , et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). Journal of the National Cancer Institute2006;98:92-100. The ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. American Journal of Obstetrics and Gynecology2003;188(6):1393-400. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. American Journal of Obstetrics and Gynecology2003;188(6):1383-92. ">ALTS 2003</a><b>(LSIL)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/673 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/675 (5.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.76 [1.18, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127/673 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95/675 (14.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.34 [1.05, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/673 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/675 (8.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09 [0.78, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/673 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58/675 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09 [0.78,1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127/673 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/675 (22.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 [0.68, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64/673 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93/675 (13.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.69 [0.51, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/673 (0.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110/675 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27.42 [10.17, 73.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0002" title="FlannellyG , AndersonD , KitchenerHC , MannEM , CampbellM , FisherP , et al. Management of women with mild and moderate cervical dyskaryosis. BMJ1994;308(6941):1399-403. ">Flannelly 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28/160 (17.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.52 [0.28, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86/160 (53.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.55 [1.32, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27/160 (16.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 [0.57, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/160 (16.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36 [0.85, 2.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/160 (36.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 [1.45, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33/160 (20.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.21 [1.55, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18/158 (11.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79 [0.40, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96/158 (60.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.37 [1.19, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/158 (15.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 [0.60, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26/158 (16.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.34 [0.84, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1 / 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55/145 (37.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/158 (32.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.18 [0.86, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/158 (44.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50 [1.22, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/158 (28.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60 [1.18, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13/145 (9.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11/158 (7.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29 [0.60, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/145 (83.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53/158 (33.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.49 [1.97, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/145 (15.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9/158 (5.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.78 [1.33, 5.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/145 (22.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12/158 (7.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.91 [1.56, 5.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98/145 (67.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44/158 (27.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.43 [1.84, 3.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/145 (45.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32/158 (20.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25 [1.57, 3.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19/160 (11.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.37 [2.15, 580.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23/158 (14.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.16 [2.65, 704.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/145 (0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38/158 (24.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.70 [4.38, 1140.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0003" title="KitchenerHC , BurnsS , NelsonL , MyersAJ , FletcherI , DesaiM , et al. A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears. British Journal of Obstetrics and Gynaecology2004;11(1):63-70. ">Kitchener 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83/130 (63.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/243 (29.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19 [1.73, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1 / 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61/130 (46.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47/243 (19.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.43 [1.77, 3.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22/130 (16.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/243 (9.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.71 [1.00, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/130 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46/243 (18.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.92 [2.01, 12.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/130 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95/243 (39.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.16 [4.24, 24.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>GHQ caseness</b> <b><sup>b</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Choice</b> <b><sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No choice</b> <b><sup>c</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Baseline</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134/233 (58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119/241 (49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16 [0.98, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 months (pre visit)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71/183 (39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77/190 (41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96 [0.75, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 months (post visit)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/175 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66/177 (37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 [0.68, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40/135 (29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/127 (28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.08 [0.73, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD009836-bbs2-0004" title="ShafiMI , LuesleyDM , JordanJA , DunnJA , RollasonTP , YatesM . Randomised trial of immediate versus deferred treatment strategies for the management of minor cervical cytological abnormalities. British Journal of Obstetrics and Gynaecology1997;104(5):590-4. ">Shafi 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 18 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/182(4.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2/171 (1.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.76 [0.81, 17.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43/182 (23.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/171 (9.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.53 [1.48, 4.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/182 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14/171(8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 [1.31, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>HPV / Koilocytic atypia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92/182 (50.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57/171 (33.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.52 [1.17, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any CIN</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88/182 (48.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51/171 (29.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.62 [1.23, 2.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 1</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/182 (24.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17/171 (9.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.49 [1.48, 4.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8/182 (4.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10/171 (5.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 [0.30, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43/182 (23.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34/171 (19.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19 [0.80, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35/182 (19.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/171 (14.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.37 [0.85, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/182 (0.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/171 (21.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.32 [5.31, 276.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Tombola 2009</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 30 months</b> <b><sup>a</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/2216 (8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101/2223 (4.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80 [1.42, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>369/2216 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>269/2223 (12.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.38 [1.19, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>188/2216 (8.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>168/2223 (7.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.12 [0.92, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Histology at 36 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>181/2216 (8.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>157/2223 (7.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16 [0.94, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 2+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>369/2216 (16.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>350/2223 (15.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 [0.93, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CIN 3+</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>188/2216 (8.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>193/2223 (8.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 [0.81, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rates:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 6 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/2216 (6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>285/2223 (12.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.88 [1.56, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Default rate at 12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>151/2216 (6.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>327/2223 (14.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.16 [1.80, 2.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pain</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any pain</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>304/782 (38.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>145/968 (15.0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.60 [2.18, 3.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/774 (18.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56/965 (5.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.21 [2.39, 4.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Bleeding</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any bleeding</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>366/781 (46.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>166/967 (17.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.73 [2.33, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>144/772 (18.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/961 (1.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.20 [6.74, 18.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Discharge</b> <b><sup>d</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Any discharge</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267/780 (34.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83/964 (8.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.98 [3.17, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate or more severe</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133/777 (17.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/962 (3.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.57 [3.20, 6.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Anxiety</b> <b><sup>e</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59/751 (7.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>121/900 (13.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58 [0.43, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>190/1161 (16.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>218/1130 (19.3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 [0.71, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>162/1050 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/1008 (17.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.72, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>179/1001 (17.9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177/962 (18.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 [0.81, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>146/949 (15.4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>143/887 (16.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 [0.77, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Depression</b> <b><sup>f</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>6 weeks</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50/757 (6.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68/902 (7.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.62, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110/1162 (9.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>132/1136 (11.6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81 [0.64, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>106/1052 (10.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>114/1016 (11.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 [0.70, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>111/1001 (11.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104/964 (10.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 [0.80, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>101/948 (10.7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108/887 (12.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 [0.68, 1.13]</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>For Immediate colposcopy, n = n at immediate colposcopy visit, possible follow‐up excluded. </p> <p><sup> a</sup> Cumulative incidence during follow‐up, excluding the exit examination or deferred treatment. </p> <p><sup> b</sup> GHQ caseness = GHQ (General Health Questionnaire) score ≥ 4. </p> <p><sup> c</sup> Analysis for this outcome between the original randomization groups. </p> <p><sup> d</sup> Based on Questionnaire 6 weeks after immediate colposcopy or first cytological surveillance visit. </p> <p><sup> e</sup> ≥ 11 on hospital anxiety and depression anxiety subscale </p> <p><sup> f</sup> ≥ 8 on hospital anxiety and depression subscale </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Reported individual outcomes in the included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/full#CD009836-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Occurence of CIN2+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Occurrence of CIN2+ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 18 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [1.12, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 24 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.66, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Occurence of CIN2+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Occurence of CIN3+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Occurrence of CIN3+ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 12 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.07 [1.54, 2.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 18 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.77, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 24 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.53, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Occurence of CIN3+ at different lengths of follow‐up: immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Histology at 12 months: immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Presence of any CIN in histology at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [1.09, 2.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Presence of CIN1/2 in histology at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.83, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Presence of CIN3+ in histology at 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.25, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Histology at 12 months: immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Histology at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 HPV/Koilocytic atypia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [1.17, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Any CIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [1.33, 3.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.3 CIN1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.58 [1.69, 3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.4 CIN2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.80, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.5 CIN2+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.66, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.6 CIN3+</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.53, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Occurence of CIN2 at different lengths of follow‐up: Immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Occurrence of CIN2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 18 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.04 [1.52, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 24 months' surveillance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.87, 2.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Occurence of CIN2 at different lengths of follow‐up: Immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Default rates: immediate colposcopy versus cytological surveillance</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Default rates <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Default rates at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.85 [1.27, 11.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Default rates at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [1.49, 29.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.3 Default rates at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.10 [9.02, 40.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Default rates: immediate colposcopy versus cytological surveillance</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance, LSIL/mild dyskaryosis only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 CIN incidence at 24 months, after LSIL/mild dyskaryosis at baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 CIN2 incidence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.66, 4.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 CIN2+ incidence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.51, 4.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.3 CIN3+ incidence at 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.39, 3.94]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance, LSIL/mild dyskaryosis only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009836-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Presence of CIN2 in histology at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.41, 5.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Presence of CIN2+ in histology at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.86, 3.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Presence of CIN3+ in histology at 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [1.11, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Histology at 24 months: immediate colposcopy versus cytological surveillance, excluding 1 trial</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009836.pub2/references#CD009836-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009836.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009836-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009836-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD009836-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009836-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD009836-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009836-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009836\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009836\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009836\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009836\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009836\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ytRBD0EW&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009836.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009836.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009836.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009836.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009836.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729537939"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009836.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729537942"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009836.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918edf557f66bd65',t:'MTc0MDcyOTUzOC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 